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Abstract for thesis part 1 – Protein Glycation Analysis 
Glycation is a non-enzymatic post-translational modification that occurs 
between free amino acid groups of proteins or peptides and carbohydrates.  This 
process affects the structure, function and stability of proteins and is accelerated 
under conditions like hyperglycaemia.  The resulting advanced glycation 
endproducts (AGEs) have implications in many age-related chronic diseases.  
Numerous analytical methods are currently employed for studying these protein 
modifications.  In this part of the thesis, I will be reporting the developments of a 
novel gel electrophoresis based affinity method for the detection and analysis of 
protein glycation.  A variety of proteins, including the most abundant circulating 
protein, human serum albumin (HSA), are examined along with more complex 
samples such as human serum and material from an Alzheimer’s Disease model.   
Our laboratory has previously shown that incorporation of a specialised 
carbohydrate affinity ligand, methacrylamido phenylboronic acid (MPBA), in 
polyacrylamide gels enabled an improved separation of carbohydrates.  In this 
thesis, the development of a boronate assisted SDS-PAGE electrophoresis method 
(mP-AGE) will be described that facilitates the separation of glycated proteins.  
This technique not only separates glycated from unmodified proteins, it also 
differentiates between different glycation states, and distinguishes glycation 
products resulting from reactions with different sugars, such as glucose 
(glucation) and fructose (fructation).  In addition, I describe further improvements 
of the mP-AGE technique in order to enhance the separation between glycated 
and unmodified proteins by utilising boronic acid gradients, carbohydrate 
imprinting, and novel 2D gel techniques.  Finally, I present a new method to 
visualise glycated proteins in complex samples prior to protein staining by using 
fluorescent boronic acid based carbohydrate ligands.  The results presented in this 
thesis show that mP-AGE is a cheap yet versatile methodology for the analysis of 
glycated proteins.  This technique may aid the development of new proteomics 
tools for the detection and separation of glycated proteins.  
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Abstract for thesis part 2 – Crystallographic analysis of proteins 
Staphylococcus aureus is a gram positive bacterium that causes a range of 
illnesses, ranging from minor skin infections to life-threatening diseases.  It 
secretes a number of soluble proteins that aid the evasion of the complement 
pathway, which is the first line of defence against microbial infections.  One of 
these proteins, Sbi (Staphylococcus aureus binder of IgG), interacts with 
components of both innate and adaptive immune systems of the host.  The 
proposed extracellular region of Sbi consists of four domains, two IgG binding 
domains (Sbi-I and II) and two additional domains (Sbi-III and IV).  Sbi-IV 
interacts with complement C3 and thus inhibits the alternative pathway.  
However, in the presence of domain III (Sbi-III-IV), it induces futile consumption 
of complement component C3.  Resolving the structure of complement inhibitory 
molecules facilitates the development of therapeutics for auto-immune diseases.  
Previous work in our laboratory showed two binding modes in the crystal 
structure between Sbi-IV and C3d.  One interaction site is located on the concave 
face of C3d, a binding site that is shared by other Staphylococcal immune 
proteins, and another on the convex side of the molecule.  In this section of the 
thesis I will be describing the expression, purification and crystallisation of Sbi-
III-IV in complex with C3d.  Sbi-III-IV was co-crystallised with C3d to gain 
understanding of the role of Sbi domain III.  However, the protein was cleaved 
during crystallisation and co-crystals of Sbi-IV and C3d were obtained in a crystal 
form that was markedly different from the previously published structure.  In this 
part of my thesis, the interactions between Sbi-IV and C3d in the two crystal 
forms will be examined.     
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Chapter 1 Introduction to protein glycation analysis 
This section of the thesis discusses the development of a novel gel 
electrophoresis based technique as a simple and cost-effective method for the 
study of protein glycation.   
 
1.1 The protein glycation process 
Post translational modification 
Post translational modifications (PTMs), such as phosphorylation and 
glycosylation, are covalent modifications of one or more amino acids that alter the 
properties of proteins.  Glycosylation is an enzyme-directed site-specific reaction 
whereby glycans are attached to proteins or peptides.  The glycoconjugates are 
diverse in structure with glycans such as glucose, galactose, mannose, fucose, 
GalNAc and GluNAc linked either by N- or O-glycosidic bonds (Figure 1- 1).  In 
mammalian cells, N-linked glycans are predominant, and are attached through the 
amino group in asparagine residues within the consensus sequence of Asn-X-
Ser/Thr where X is any amino acid other than proline.  There are no specific 
sequences for O-linked glycosylation, which takes place through the hydroxyl 
group of serine, threonine and hydroxylysine (Taylor and Drickamer, 2006).  Due 
to their heterogeneity, glycans are often removed from glycoproteins prior to 
analysis like X-ray crystallography and nuclear magnetic resonance (NMR) 
spectroscopy.     
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Figure 1- 1 Examples of glycosylated protein adducts, N- (left) and O-linked (right). 
Structures are generated using ChemDraw (Cambridgesoft) adapted from Voet and Voet 
(1995).  
In addition to glycosylation, a non-enzymatic reaction also takes place in 
the presence of amino acids and sugars, either endogenously or exogenously.  The 
endogenous process is often referred to as glycation and is associated with various 
chronic diseases, such as diabetes, ageing and Alzheimer’s Disease.  The 
exogenous process is called the Maillard reaction, which is named after Louis-
Camille Maillard who first described the process in the early 1900s (Maillard, 
1912).  This process occurs during cooking, and gives food aroma, taste and 
colour.  The reaction also results in reduced nutritive value of food and forms 
toxic compounds that are harmful to human health (Chobert et al., 2006).   
 
Glycation 
Protein glycation involves a complex cascade of reactions initiated with the 
condensation reaction between carbonyl groups of reducing sugars and amino 
acids of proteins or peptides, such as lysine, arginine or the protein’s amino 
terminus, to form a Schiff base (Figure 1- 2).  This unstable Schiff base 
intermediate spontaneously rearranges to form a more stable ketoamine called the 
Amadori product.  At this early stage of the process, the reaction is reversible but 
accumulation of the Amadori product intermediate occurs owing to the slower 
reverse reaction.  This Amadori product then undergoes a series of partially 
characterised reactions including oxidation, fragmentation, dehydration, 
cyclisation and degradation to form heterogeneous products that are collectively 
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known as the advanced glycation endproducts (AGEs).  AGE formation is 
irreversible and these products accumulate over the lifetime of proteins.  
Glycation can occur to any protein, both within the cell or in extracellular 
compartments.  The glycation process is slow and consequently mainly affects 
long-lived proteins (Lapolla et al., 2005).  Therefore, the rapid turnover of most 
proteins protects them against such damage (Pokharna and Pottenger, 1997).  
Endogenous formation of AGEs and their intermediates are more rapid during 
environmental stress such as hyperglycaemia and oxidative stress (Stirban and 
Tschoepe, 2008).  Accumulation of glycation adducts is associated with protein 
denaturation, enzyme inactivation as well as cellular mediated immune response 
(Thornalley, 1999).   
 
Figure 1- 2 The protein glycation process.  Reducing sugars, such as glucose and fructose, 
react with free amino groups of proteins and peptides to form Schiff bases.  This 
intermediate rearranges into a more stable Amadori product that subsequently undergoes 
a cascade of complex reactions to form heterogeneous compounds known as the 
advanced glycation endproducts (AGEs).  AGEs have implications in various age-related 
chronic diseases. 
 
The Maillard reaction 
Diet has been identified as the main source of sugar and pre-formed AGEs 
(Danby, 2010), yet little is known about the resorption and elimination of these 
dietary glycated products.  Ahmed and colleagues (2005) have reported low 
bioavailability of AGE residues of ingested food, with only 10% of the ingested 
AGEs absorbed into the body and subsequently cleared by macrophages and 
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excreted by the liver.  Nevertheless, a considerable amount of these exogenous 
AGEs (70 – 95%) is retained in the body where they exert various physiological 
effects (Araki et al., 1995, Stirban and Tschoepe, 2008).  Foerster and Henle 
(2003) have shown that the high temperatures used in food preparation result in 
different glycation products from those observed in biological systems.  The rate 
of reaction is also quicker as the concentration of open chain glucose is 
approximately quadrupled when the temperature of the solution is raised from 20 
to 60oC (Vrdoljak et al., 2004). 
 
1.2 Model proteins for studying protein glycation 
Haemoglobin  
Haemoglobin (Hb) is an oxygen-transport protein with a lifespan of around 
120 days.  The Diabetes Control and Complications Trial (DCCT) and the United 
Kingdom Prospective Diabetes Study (UKPDS) showed correlation between 
levels of glycated haemoglobin isoform HbA1c and the development and 
progression of long-term complications of diabetes.  However, these 
measurements do not always associate with glycaemia and the advancement of 
symptoms.  Hence, they should be compared with the results obtained from other 
diagnostic methods (Homa and Majkowska, 2010).   
Glycation is a slow reaction.  At the normal blood glucose concentration of 
5 mM, approximately 0.01% of amino groups are modified per day, or a glycation 
rate of 0.2% Hb per day.  The total glycated haemoglobin (GlcHb) has been 
reported to account for almost a quarter of haemoglobin at the end of the 
erythrocyte lifespan.  Even for an individual with normal blood sugar level, an 
average of 12% GlcHb is present (Zhang et al., 2008, Bunn et al., 1979).  
Kilpatrick and colleagues (1996) reported an increase in the extent of glycated 
proteins with age, with the average HbA1c rising from 3.8 to 4.4% for individuals 
of 20 to 70 years of age.   
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Owing to the half-life of proteins, glycated haemoglobin measurements 
thus reveal blood glucose concentration of the preceding six to eight weeks, whilst 
glycated albumin reveals the concentration over the previous two to three weeks.  
Hence, measurement of HbA1c and glycated albumin can be used to determine the 
long- and medium-term glycaemia of a patient respectively (Kouzuma et al., 
2002). The rate of glycation varies between proteins.  Albumin, for example, is 
estimated to be glycated nine times faster than Hb (Garlick and Mazer, 1983), and 
various studies have now indicated that glycated HSA is a better glycaemic 
indicator than glycated haemoglobin (Inaba et al., 2007).   
 
Human serum albumin  
Human serum albumin (HSA, Figure 1- 3) is the most abundant circulating 
protein in human plasma (40 mg/ml) and binds a range of compounds, from 
amino acids and hormones to drugs (Curry et al., 1998).  Albumin provides an 
antioxidant property, trapping 70% of the free radicals in serum (Roche et al., 
2008).  It has a half-life of approximately 20 days.  In healthy individuals, around 
10% of HSA is glycated, usually at lysine and arginine residues.  The level of 
glycation can increase two- to three-fold under hyperglycaemic conditions 
(Sattarahmady et al., 2007).  Lysine is the most abundantly glycated residue in 
HSA, with almost half of the lysines being modified.  These lysines are located 
adjacent to basic amino acids like histidine (Méndez et al., 2010).   
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Figure 1- 3 Crystal structure of human serum albumin (HSA).  HSA is composed of a 
single polypeptide chain arranged in an 80 x 80 x 30-Å heart shape, with three 
homologous domains, I, II, and III; each with two subdomains, A and B.  The bottom 
images show its main glycation sites (lysine residues in green on left, arginine in yellow 
on right) (Rondeau and Bourdon, 2011, Mendez et al., 2005).   
The extent of glycation can reach 20 or 30% in long-lived proteins (Garlick 
and Mazer, 1983) and can therefore be used as disease indicators.  For this reason, 
development of analytical tools for the detection and analysis of glycated proteins 
is vital for diagnosis and minimising long-term disease complications.   
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1.3 Current analytical methods for the study of protein glycation 
Owing to the implications in age-related diseases, glycation has been 
widely studied for almost a century.  Despite these extensive studies, the glycation 
process is only poorly understood (Pokharna and Pottenger, 1997).  This is 
primarily due to the complex and diverse structures formed.  Currently, numerous 
techniques have been exploited for the analysis of glycated proteins including 
chromatography, mass spectrometry (MS), and fluorescence spectroscopy 
(Preinerstorfer et al., 2009, Lamari et al., 2003, Priego Capote and Sanchez, 2009, 
Zhang et al., 2008, Nicholls and Paul, 2004).  The cost and equipment availability 
remain the major drawback of some of these techniques, often limiting them to 
specialised laboratories.  We will present a brief overview on the challenges 
associated with the analysis of glycated proteins by discussing the pros and cons 
of some of the commonly used techniques. 
 
Mass Spectrometry  
Mass Spectrometry (MS) became a useful tool for characterising biological 
macromolecules like proteins and peptides in the late 1980s because of the 
development of soft ionisation techniques.  Whilst proteins with masses up to 
1000 kDa can be analysed, the most widely used MS techniques are limited to 
studying individual subunits as oligomeric proteins dissociate into their 
constituent monomers during ionisation.  Commonly used electrospray ionisation 
(ESI) requires proteins to be soluble in volatile, polar solvents such as acetonitrile 
with formic acid for positive ion (MH+) formation, or acetonitrile with ammonium 
hydroxide for negative ion (M-) detection.  MS can be used to determine 
individual protein modifications, as less than 0.01% error is achievable.  This 
error equates to less than 5 Da disparity for a 50 -kDa protein (Price and Nairn, 
2009).  However, MS-based proteomics techniques, like matrix-assisted laser 
desorption ionization (MALDI) or ESI, are biased towards the most abundant 
proteins, which especially complicates the analysis of complex sample mixtures.  
To enable the detection of less abundant proteins, MS analysis is often coupled 
9 
 
with chromatography or gel electrophoresis for advance separation of proteins.  
Direct analysis of the heterogeneous AGE-modified proteins are also difficult as it 
results in poorly resolved broad peaks (Niwa, 2006).  MS sample preparation 
involves sample digestion or modification, resulting in the loss of glycan linkage 
information.  Specialised instruments are also required, along with high 
maintenance cost and complex data analysis.   
 
Chromatography 
Boronate affinity chromatography (BAC) is a high throughput method used 
to selectively enrich glycated proteins in complex sample mixtures prior to other 
analyses such as MS.  This method is based on the interaction between boronic 
acid and cis 1,2-diols found in sugars.  Non-glycated species are not bound to the 
boronate resin, whilst the retained glycated proteins are eluted by lowering the pH 
of the buffer, or by adding a source of hydroxyl groups.  Nevertheless, BAC is not 
specific to the Amadori product but also binds other modified proteins such as 
those with deoxyglucosones and phosphorylated sugars (Zhang et al., 2008). 
The enzymatic digestion and sample derivatisation often performed prior to 
HPLC chromatographic analyses can be damaging for the carbohydrate 
modifications.  For example, hydrolysis of tissue proteins is carried out by heating 
in strong acid like 6M HCl at 110°C for 24 h prior to their analysis to release 
glycated products.  Glycated lysines and some AGEs, however, are not stable 
under these conditions.  Alternatively, protein-bound Amadori products are 
reduced to alcohols using sodium borohydride.  The amount of hexitollysine can 
then be quantified after acid hydrolysis (Zhang et al., 2008).  Nevertheless, prior 
sample knowledge or internal standards are required to establish the presence of 
modified proteins based on retention times on HPLC analysis which can be time 
consuming.   
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Fluorescence spectroscopy 
Fluorescence spectroscopy can be used to determine the extent of glycation 
because AGEs have specific fluorescence at excitation/emission wavelengths at 
330/395 nm, 365/440 nm and 485/530 nm (Schmitt et al., 2005).  However, this 
method is limited to the detection of fluorescent AGEs and does not provide 
identity or structural information of the glycation adducts.   There may also be 
interference from non-AGE fluorescent compounds. 
 
There is currently no assay that can exclusively detect all AGE compounds.  
Immunoassays have been developed using AGE antibodies, but the 
reproducibility and sensitivity of this method remains a set-back (Ahmed et al., 
2005).  There are also no reports of specific assays for detecting the inhibition of 
early stage glycation or Amadori intermediates (Rahbar and Nadler, 1999).   
 
1.4 Utilisation of boronic acid for analysis of protein glycation 
Boronic acids are well-known for their reversible covalent interaction with 
cis diols, and are used for numerous sensing and separation applications 
(Nishiyabu et al., 2010a, Nishiyabu et al., 2010b).  The interaction between 
boronic acid and diols was first described by Kuivila et al. in 1954 and 
subsequently studied by Lorand and Edwards in the 1959 using pH depression 
method (Kuivila et al., 1954, Lorand and Edwards, 1959).  Both the neutral and 
anionic forms of boronic acid can interact with 1,2- and 1,3-diols to form five- 
and six-membered cyclic esters (Figure 1- 4), with a four-fold increase in the 
interconversion of the tetrahedral form compared to the trigonal analogue (James 
et al., 2006, Matsumoto et al., 2010).  The equilibrium rate is comparable to that 
of non-covalent interactions (Wulff, 1995).   
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Figure 1- 4 Boronic acid interaction with diols.  Trigonal phenylboronic acid becomes an 
anionic boronate form at high pH.  Both states can interact with cis 1,2- and 1,3-diols in a 
reversible covalent manner to form cyclic esters.   
 
Phenylboronic acids have different affinities for different sugars.  The 
binding affinities between boronic acid and diols were examined by Springsteen 
and Wang (2002) under specific experimental conditions (Table 1- 1). 
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Table 1- 1 Phenylboronic acid binding affinities for various diol molecules at 25oC in 
water.  Saccharide structures containing anomeric diols favourable for boronic acid 
binding are shown along with their percentage in D2O solution (James et al., 2006). 
Polyol K mol-1 Structure Relative percentage (of 
total composition in 
D2O) 
1,3-propanediol 0.88   
D-glucose 110 
 
α-D-glucofuranose 
0.14 
D-mannose 170 
 
β-D-mannofuranose 
0.3 
D-galactose 280 
 
α-D-galactofuranose 
2.5 
D-fructose 4400 
 
β-D-fructofuranose 
25 
Catechol 18000   
Phenylboronic acid is the chosen ligand for this electrophoresis study due to 
its saccharide sensing ability in aqueous medium (James et al., 2006, James, 2005, 
James and Shinkai, 2002, Klenk et al., 1982, Scrafton et al., 2008).  Boron affinity 
based electrophoresis analysis has been developed in our laboratory previously to 
improve the electrophoretic separation of saccharides according to their charge to 
mass ratio (Jackson et al., 2008).  Subsequently, it is reasoned that the gel-
incorporated boronic acid molecules would also interact with carbohydrate-
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modified protein adducts to facilitate the detection and separation of glycated 
proteins.   
 
1.5 Project objectives and overview 
Protein glycation is a post-translational modification associated with 
various age-related chronic diseases.  With the growing need for analytical 
techniques to detect and identify glycated proteins, much of the research effort has 
been devoted to the utilisation of state-of-the-art equipment with less emphasis on 
the development of a widely accessible technique.  The aim of this thesis is to 
report the development of a simple and inexpensive method that exploits the 
widely used gel electrophoresis system for the study of protein glycation.  SDS-
PAGE alone cannot differentiate between glycated and unaffected proteins due to 
their small molecular mass difference.  To utilise this analytical system, we have 
incorporated a carbohydrate affinity ligand, methacrylamido phenylboronic acid 
(MPBA), into polyacrylamide gels that interacts with the carbohydrate moiety of 
the affected proteins.  We hypothesise that glycated proteins can be separated 
from unmodified ones based on their affinity for the gel-incorporated boronic 
acid, and therefore could become a useful disease diagnostic tool. 
The methodology of boronic acid incorporation is described in Chapter 3, 
along with the analysis of in vitro glycated proteins.  HSA is the key protein being 
investigated in this study due to its abundance in blood plasma and high glycation 
rate.  The scope of this study extends to a number of other noteworthy proteins.  
Lactoglobulin was investigated to provide an insight into exogenous glycation, as 
this milk protein is exposed to high temperature treatment during food processing.  
In addition, we examined the glycation of prion proteins because of its association 
with neurodegenerative diseases.  Our protein glycation examination also includes 
the analysis of a recombinant protein which is gluconoylated during recombinant 
protein production in an E. coli expression system.  Further improvements of this 
electrophoresis technique are reported in Chapter 4, which include ligand 
templating, boronic acid gradients and novel 2D gel methodologies to increase 
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glycated protein separation.  Furthermore, the use of fluorescence for the 
visualisation of glycated proteins is addressed in Chapter 5.  Lastly, Alzheimer’s 
Disease transgenic mouse brain samples are analysed with this technique (Chapter 
6).  
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Chapter 2 Materials and Method for gel electrophoresis studies 
2.1 Chemicals  
All chemicals were purchased from Sigma-Aldrich, and all solvents from 
Fisher Scientific UK Ltd, Thermo Fisher Scientific unless otherwise stated. 
Protein molecular weight markers were purchased from Fermentas, Thermo 
Fisher Scientific.  Samples were dialysed using SnakeSkinTM dialysis tubing, 3.5 
K MWCO from Pierce, Thermo Fisher Scientific Inc.  
 
2.2 Gel electrophoresis equipment 
Novex® Xcell SurelockTM Mini-cell vertical electrophoresis tank, mini-gel 
cassettes (dimensions: height 100 mm × width 100 mm × thickness 1.0 mm) and 
DryEase® Mini-gel drying kit (drying frame, clamps, drying base and cellophane) 
were purchased from Invitrogen Ltd, and PowerPac 300 was obtained from Bio-
Rad.  
 
2.3 SDS-PAGE Buffers 
Polyacrylamide gels are characterised by the percentage of acrylamide 
(%T) and crosslinker (%C) present.  %T = [acrylamide (g) + bisacrylamide (g) x 
100] ÷ volume (ml), and %C = [bisacrylamide (g) x 100] ÷ [acrylamide (g) + 
bisacrylamide (g)]   
Resolving gel – Acrylamide solution (acrylamide: bisacrylamide 29:1) in 375 mM 
Tris pH 8.8, polymerised with 3 µl TEMED and 31 µl 10% (w/v) APS. 
8% polyacrylamide mini gels were prepared with 1.25 ml of 40% acrylamide 
solution, 1.56 ml 1.5 M Tris pH 8.8 and 3.40 ml Milli-Q water. 
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15% polyacrylamide mini gel utilised 2.34 ml 40% acrylamide solution, 1.56 ml 
of 1.5 M Tris pH 8.8 and 2.31 ml Milli-Q water. 
Other percentage gels were prepared in a similar way by varying acrylamide 
concentration. 
Stacking gel – 4% polyacrylamide (acrylamide: bisacrylamide 29:1) in 125 mM 
Tris pH 6.8 polymerised with 3 µl TEMED and 16 µl of 10% (w/v) APS. 
For each mini gel, 0.78 ml of 0.5 M Tris pH 6.8, 0.31 ml of 40% acrylamide 
solution and 2 ml Milli-Q water was used. 
1x glycine running buffer – 25 mM Tris, 190 mM glycine and 0.1% (w/v) SDS 
pH 8.3 
2x reducing sample loading buffer – 62.5 mM Tris pH 6.8, 3% (w/v) SDS, 5% 
(v/v) β-mercaptoethanol, 10% (v/v) glycerol and 0.01% (w/v) bromophenol blue. 
Coomassie Brilliant Blue (CBB) staining solution – 0.1% (w/v) Coomassie Blue 
R250, 40% (v/v) methanol, 10% (v/v) glacial acetic acid and 50% (v/v) Milli-Q 
water. 
Destain solution – 25% (v/v) methanol, 10% (v/v) glacial acetic acid and 65% 
(v/v) Milli-Q water. 
Drying solution – 30% (v/v) methanol, 10% (v/v) glacial acetic acid, 10% (v/v) 
glycerol and 50% (v/v) Milli-Q water. 
 
2.4 Synthesis of methacrylamido phenylboronic acid  
Methacrylamido phenylboronic acid (MPBA) is commercially available or 
synthesised as described below (Figure 2- 1). 
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Figure 2- 1 Synthesis of methacrylamido phenylboronic acid (MPBA).   
Preparation of N-(3-(5,5-dimethyl-1,3,2-dioxaborinan-2yl)phenyl)methacrylamide 
2,2-Dimethylpropanediol (Acros Organics, Thermo Fisher Scientific, 0.805 
g, 7.73 mmol) was added to a 100 ml round-bottom flask containing 3-
aminophenylboronic acid monohydrate (3-APBA, Frontier Scientific Inc, 1.201 g, 
7.75 mmol) in 50 ml chloroform.  The resulting suspension was stirred overnight 
(22 h), after which the reaction mixture was filtered and solvent evaporated in 
vacuo yielding the intermediate 3-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)aniline 
(1.522 g, 96% yield): 1H NMR (δ; 300 MHz; CDCl3) 0.93 (6H, s, 2 × CH3), 3.70 
(4H, s, 2 × OCH2), 6.78 (1H, ddd, J 7.7, 2.6, 1.2, Ar CH), 7.15 (3H, m, Ar CH); 
13C{1H} NMR (δ; 75 MHz; CDCl3) 22.3 (2 × CH3), 32.3 (Cq), 72.7 (2 × OCH2), 
118.0 (Ar CH), 120.8 (Ar CH), 124.6 (Ar CH), 129.0 (Ar CH), 146.0 (Ar CN); 
11B{1H} NMR (δ; 96 MHz; CDCl3) 27.52 bs.  m/z (ESI positive) found 206.1351 
([M+H]+, C11H17BNO2, requires 206.1352). 
The entire sample of 3-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)aniline 
(1.522 g, 7.42 mmol) was dissolved in 15 ml dichloromethane (DCM), to which 
triethylamine (1.03 ml, 7.42 mmol) was added.  The obtained solution was stirred 
at 0°C under nitrogen.  Further, a solution of methacryloyl chloride (0.73 ml, 7.47 
mmol) in DCM (5 ml) was slowly added over two hours.  The solution was 
allowed to warm to room temperature and stirred for a further 30 min.  The 
reaction mixture was washed with water (3 x 10 ml), dried over magnesium 
sulphate, filtered and dried in vacuo.  1.384 g of off-white powder was obtained 
(68% yield). 1H NMR (δ; 300 MHz; CDCl3) 0.93 (6H, s, 2 × CH3), 1.99 (3H, s, 
CH3), 3.70 (4H, s, 2 × OCH2), 5.40 (1H, m, C=CHH), 5.72 (1H, m, C=CHH), 
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7.25 (1H, t, J 7.7, Ar CH), 7.45 (1H, dt, J 7.4, 1.0, Ar CH), 7.82 (1H, m, Ar CH); 
13C{1H} NMR (δ; 75 MHz; CDCl3) 19.1 (methacryl CH3), 22.3 (2 × CH3), 32.3 
(Cq), 72.7 (2 × OCH3), 120.1 (methacryl CH2), 122.9 (Ar CH), 125.4 (Ar CH), 
128.9 (Ar CH), 130.3 (Ar CH), 137.6 (methacryl Cq), 141.4 (Ar CN), 166.8 (C=O 
amide); 11B{1H} NMR (δ; 96 MHz; CDCl3) 27.41 bs.  m/z (ESI positive) found 
274.1617 and 296.1447 ([M+H]+, C15H21BNO3, requires 274.1614; [M+Na]+, 
C15H20BNO3Na, requires 296.1434) (Jackson et al., 2008).   
 
2.5 Analysis of boronic acid molecules 
2.5.1 Mass Spectrometry of MPBA 
Mass spectra were generated using a micrOTOF electrospray time-of-flight 
(ESI- TOF) mass spectrometer (Bruker Daltonik GmbH) at the University of 
Bath.  Ten microliters of sample was injected into a 30:70 flow of 
water/acetonitrile at 0.3 ml/min to the instrument.  The nitrogen nebulising gas 
was applied at a pressure of 1 bar.  Nitrogen was also used as a drying gas, which 
was supplied at a flow rate of 8 L/min and a temperature of 200°C.  Positive ion 
mode was used with a corresponding capillary voltage of -4000 V and negative 
ion mode with +4000 V.  Only full scan data was acquired.  In each acquisition 10 
µl of 5 mM sodium formate clusters was injected after the sample to act as a 
calibrant over the mass range of 50 – 1500 m/z.  Data acquisition and automated 
processing were controlled via Compass Open Access 1.2 software, and 
calculations regarding theoretical mass and isotope patterns were carried out by 
the Bruker data processing software, DataAnalysis 3.4.  
 
2.5.2 Nuclear magnetic resonance spectroscopy 
Nuclear magnetic resonance (NMR) spectra were run in chloroform-d or 
deuterated oxide in a Bruker AVANCE 300 equipment.  1H NMR spectra were 
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recorded at 300 MHz, 11B{1H} NMR spectra at 96 MHz and 13C{1H} NMR 
spectra at 76 MHz.  Chemical shifts (δ) are expressed in parts per million (ppm) 
and are reported relative to the residual solvent peak or to tetramethylsilane 
(TMS) as an internal standard in 1H and 13C{1H} NMR spectra, and boron 
trifluoride diethyl etherate as an external standard in 11B{1H} NMR spectra.  The 
multiplicities and general assignments of the spectroscopic data are denoted as 
singlet (s), doublet (d), triplet (t), quartet (q), quintet (quin), doublet of doublets 
(dd), doublet of triplets (dt), triplet of triplets (tt), unresolved multiplet (m), broad 
(br) and aryl (Ar).  Coupling constants (J) are expressed in Hz. 
 
2.6 Analysis of polyacrylamide gels 
2.6.1 Dye displacement reaction of Alizarin Red S 
To determine the diol binding ability of boronic acid (MPBA) in hydrogel, 
a series of dye uptake and displacement experiments were carried out using 
Alizarin Red S (ARS, Figure 2- 2).  In this investigation, the hydrogel consists of 
19.5% (w/v) acrylamide and 0.5% (w/v) bis-acrylamide, with or without MPBA 
(1% w/v).  1 ml of the solution was polymerised with 2.5 µl of TEMED and 7.5 µl 
of 10% (w/v) APS.  The polyacrylamide solution was poured into a mould (Laser 
Lines Ltd., Figure 2- 3) and allowed to set.  The ball was then removed from the 
mould and placed in a 5 ml round bottom flask containing 1 ml 2.5x10-4 M ARS 
solution (pH 7.2) and gently rotated (60 rpm).  Absorbance readings at 513 nm 
were taken at regular intervals.  After saturation with ARS dye, the ball was 
removed, briefly dried with tissue paper and placed in 1 ml of PBS solution and 
gently rotated (60 rpm).  When the absorbance readings plateau, fructose was 
added to displace the remaining ARS from the gel ball.  This was done by placing 
the ball in 1 ml PBS and adding fructose to the solution.  The absorbance readings 
were taken 30 min after each addition to allow sufficient time for displacement to 
take place (Pereira Morais, 2008, Ma et al., 2009). 
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Figure 2- 2 Alizarin Red S (ARS) dye staining, washing and displacement procedure for 
polyacrylamide gel balls.  PA and MPBA gel balls were each placed in ARS solution and 
gently rotated until saturation.  The balls were then briefly dried and transferred to PBS 
solution for washing.  The remaining dye molecules were displaced from the gels with 
fructose.   
 
Figure 2- 3 The mould used for casting gel balls of 5 mm diameter.  It was designed using 
Rhinoceros (Version 3.0, Robert McNeel & Associates) and made by Laser Lines Ltd., 
UK (Ma et al., 2009). 
 
2.6.2 Scanning electron microscopy of gels  
8% polyacrylamide (PA) and 8% PA with 0.5% (w/v) MPBA gels were 
polymerised in 1-ml syringes, resulting in 5-mm diameter cylinders which were 
cut in 1.5 cm lengths.  Water was removed from the gel pieces using a fixative of 
2.5% glutaraldehyde in 0.15 M sodium cacodylate buffer pH 7.2.  After overnight 
fixation at 4oC, samples were rinsed with 0.1 M sodium cacodylate buffer pH 7.3.  
After post-fixing the gels with 1% osmium tetraoxide for one hour, they were 
rinsed in deionised water twice, and dehydrated step-wise in ethanol using 50%, 
70%, 95% and absolute ethanol.  Each concentration was soaked for 10 minutes 
and then repeated.  Finally, samples were left in 100% ethanol for two hours and 
cut while submerging in absolute ethanol and dried with two different methods: 
critical point drying (CPD) or hexamethyldisilazane (HMDS). 
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For critical point drying, samples were placed into a basket on the critical 
point dryer boat and ethanol removed by 30-minute repeated flushing of liquid 
carbon dioxide.  Temperature was raised to 35oC at around 1200 psi pressure.  
The pressure was then slowly released whilst the temperature increased to around 
40oC. 
For the HMDS drying method, samples were placed in a 50:50 mixture of 
ethanol and HMDS for 15 min.  The solution was then replaced with fresh HMDS 
twice; each time soaking for 15 min.  The samples were placed on a petri dish and 
dried with silica gel overnight. 
Gels dried with both methods were cut into cross-sectional and longitudinal 
pieces and mounted on scanning electron microscopy (SEM) specimen holders.  
Samples were coated with gold using vacuum evaporation and sputtering 
(Edwards Sputter coater) before SEM images were taken (JEOL JSM-6480LV).  
 
2.7 In vitro glycation of proteins 
Proteins were incubated with PBS or 50 mM sugar in a water bath or dry 
heating block at 37˚C under aseptic conditions.  Proteins were dialysed and frozen 
until analysis.   
The proteins investigated include HSA (10 and 20 mg/ml), Sbi (1.5 mg/ml), 
lactoglobulin (10 mg/ml), prion protein (11 µM) and human serum (Lonza).  
Recombinant mouse Prp was supplied by David Brown, Department of Biology 
and Biochemistry, University of Bath (Davies et al., 2009).  Some of the protein 
incubation and initial mP-AGE investigation were performed by Savroop Bhamra 
under my supervision as part of her BSc project. 
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2.8 Analysis of glycated proteins 
2.8.1 Mass spectrometry of glycated proteins 
HSA samples were dialysed overnight at 4oC.  20 µl of 50:50 acetonitrile: 
formic acid was added to 100 µl of sample to aid ionisation.  Samples were 
introduced to a time-of-Flight micrOTOFTM mass spectrometer from Bruker 
Daltonics coupled with an electrospray source (ESI-TOF) using a syringe pump.  
The samples were analysed in positive electrospray ionisation mode with a flow 
rate of 4 µl/min.  Data was acquired for an average of 5 min to generate an 
averaged mass spectrum. The instrument was calibrated post sample analysis 
using a sodium formate solution.  Data was processed using external calibration 
with the Bruker Daltonics software, DataAnalysisTM as part of the overall 
hardware control software, Compass 1.1TM. 
 
2.8.2 Fluorescence analysis 
To determine the relative protein concentration, samples were excited at 
295 nm and absorbance spectra were recorded between wavelengths of 300 – 450 
nm.  For the analysis of AGE content of glycated protein samples, fluorescence 
emission spectra were recorded between 400 – 550 nm using 370 nm excitation 
wavelength.  Spectrophotometer FluoroSENS (Gilden Photonics) was used for the 
reported measurements. 
 
2.8.3 Western blot analysis of gluconoylated Sbi 
Sbi-III-IV (1.8 mg/ml) was incubated with 50 mM gluconolactone at 37oC 
for 30 min.  Fresh and incubated Sbi samples were electrophoresed in 15% 
polyacrylamide gel and another in the presence of 0.2% (w/v) MPBA.  The 
samples were transferred onto nitrocellulose membrane by Western blotting.  The 
membranes were placed in blocking buffer of 2% bovine serum albumin (BSA) in 
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Tris-acetic acid-EDTA buffer (TAE) overnight at 4oC with rocking.  The solution 
was removed and anti-Sbi rabbit antibody was added at a 1:10,000 dilution with 
blocking buffer and shaken for 1 h.  Three 15 ml washes were performed with 
Tris buffered saline (TBS).  Secondary anti-rabbit antibody was then added at a 
ratio of 1:5,000 blocking buffer, again rocking for 1 h.  Three 15 ml TBS washes 
were performed and the developer added.  
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Chapter 3 Development of a novel glycation analysis method using 
boronate affinity electrophoresis 
3.1 Introduction 
Polyacrylamide gel electrophoresis was first described in 1959 (Davis and 
Ornstein, 1959, Raymond and Weintraub, 1959).  It is now routinely used for the 
analysis of proteins to determine their purity.  The principle of gel electrophoresis 
is based on the fact that proteins are amphoteric, i.e. they are charged at any pH 
except their isoelectrc point (pI).  Therefore, they will migrate in the presence of 
an electric field.  The rate of protein migration depends on various factors, 
including the field strength, net charge, shape and size of the molecule, as well as 
the ionic strength, viscosity and temperature of the medium.  The polyacrylamide 
gel matrix acts as a molecular sieve.  The gel pore size is adjustable by varying 
the amount of acrylamide and crosslinkers used, enabling the separation of protein 
with different molecular mass ranges.  Under denaturing conditions, using 
dithiothreitol (DTT) or β-mercaptoethanol, and in the presence of sodium dodecyl 
sulphate (SDS), proteins are linearised and uniformly coated with negative 
charges.  Therefore, their electrophoresis migration depends on the molecular 
weight of the proteins.   
Electrophoresis is a simple and highly reproducible technique that is widely 
used for protein analysis.  The method is rapid, and direct comparisons between 
numerous samples are possible due to their simultaneous analysis.  The gel is 
chemically inert and stable over a range of temperatures and pHs.  Electrophoresis 
is sensitive and detects pico moles of proteins when silver staining is used 
(Switzer et al., 1979).  1 – 2% changes in protein mass are detectable with this 
technique, which is equivalent to a 4 amino acid difference in a 50 -kDa protein.  
Size estimation by SDS-PAGE, however, has an accuracy of only 10% because 
some proteins bind less SDS and migrate anomalously (Zhang et al., 2008, Patel, 
1994).  Consequently, gel electrophoresis cannot differentiate between glycated 
and unmodified proteins because of their small molecular weight differences.  In 
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3.3 Results 
In this chapter I will first examine the properties of boronic acid-
incorporated polyacrylamide gels using a dye displacement assay and scanning 
electron microscopy.  In vitro glycated proteins are subsequently analysed with 
the newly developed boronate assisted gel electrophoresis method, after 
examining the glycation levels of the samples using fluorescence and mass 
spectrometry. 
  
3.3.1 Analysis of hydrogel properties of boronic acid gels 
3.3.1.1 Dye displacement of boronic acid gels 
The diol binding ability of MPBA in polyacrylamide (PA) gels was 
investigated using an organic dye, Alizarin Red S (ARS), in an indicator 
displacement assay (IDA, Figure 3- 2).  PA gels in the presence and absence of 
MPBA were cast into gel balls according to the method described in 2.6.1.  
Spectroscopy was utilised to monitor the dye uptake and release by measuring the 
absorbance of the solution incubating the gel balls at 513 nm at regular intervals.  
Both gel balls were colourless after polymerisation.  Upon ARS staining, the PA 
gels turned red, similar to the colour of the ARS solution, whilst the boronic acid 
ones turned orange.  The MPBA gel balls also retained more dye molecules 
compared to the control (Figure 3- 3).  After dye saturation, the balls were placed 
in PBS buffer to remove any unbound dye molecules.  A similar amount of dye 
was released from both gels.  The PA gels appeared a very pale pink at this stage 
whilst the MPBA one was still orange. 
 Figure 3- 2 Boronic acid interaction with Alizarin Red S (ARS).  (A) ARS stained 
polyacrylamide gel slab (middle) and MPBA gel (right).  Prior to staining, both gels 
colourless.  Upon ARS addition
acid one turns orange.  (B) 
dye molecule.  The dye is then disp
The dye molecule
competitively displaced 
released from the MPBA gel
dye and MPBA, which was subsequently displaced
Figure 3- 3 Alizarin Red S (ARS) dye uptake 
measurements.  Solutions incubating the gel balls were measure
more ARS was absorbed by 
fructose.   
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3.3.1.2 Scanning electron microscopy of hydrogel 
Scanning electron microscopy (SEM) was used to characterise surface 
morphology and internal structure of the hydrogels.  The observed gel structure 
and pore size of PA gels in the presence of MPBA could be used to assess the 
effect of boronic acid incorporation.  The SEM images (Figure 3- 4) under the 
magnification of x 1400 (gel images 1 and 3) showed average pore sizes of around 
1 µm in diameter.  When the gel samples were inspected under higher 
magnification (x 20000, images 2 and 4), however, the smaller pores can be 
observed, which were approximately 0.1 µm in diameter.  Both gels with (B) and 
without MPBA incorporated (A) have sponge-like appearances with uniform 
polymer strands, and similar pore sizes, indicating that the incorporation of 
MPBA does not significantly affect the structure of the PA hydrogel.   
 Figure 3- 4 Scanning electron microscopy (SEM) image
8% PA gel without MPBA (A) and with 0.5% 
drying (CPD; 1 and 2) and 
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3.3.2 In vitro glycation of human serum albumin 
Fluorescence spectroscopy and MS analyses were carried out to determine 
the extent of glycation in the in vitro incubated human serum albumin (HSA) 
samples.   
3.3.2.1 Fluorescence spectroscopy analysis of glycated HSA 
Fluorescence spectroscopy enables the quantification of fluorescent AGE 
products that are present in the sample, such as pentosidine and crossline (Figure 
3- 5).  Figure 3- 6 shows the fluorescence spectrum of HSA after incubation with 
a variety of sugars at 37oC for 21 days.  HSA glycated with fructose gave the 
highest level of fluorescence, suggesting a higher glycation rate compared to other 
sugars.  Glucose and mannose modified HSA yielded a similar fluorescence 
profile, and that incubated with maltose resulted in the least amount of fluorescent 
AGE. 
 
Figure 3- 5 Chemical structures of some fluorescent advanced glycation endproducts 
(Ulrich and Cerami, 2001). 
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Figure 3- 6 Fluorescent analysis of glycated HSA.  HSA has been incubated with PBS, 
glucose, fructose, mannose and maltose at 37oC for 21 days.  The samples were excited at 
370 nm and emission was measured from 400 to 550 nm. 
 
3.3.2.2 Mass Spectrometry of glycated HSA 
Whilst fluorescence spectroscopy is biased towards fluorescent products, 
MS detects the accurate mass of the protein, enabling the number of modifications 
to be calculated.   Fatty acid-free HSA has a molecular weight around 66440 Da 
(Meloun et al., 1975).  In addition to the native HSA, additional peak clusters 
were identified in a commercially obtained HSA sample, ranging from 66316.6 to 
68089.1 Da.  The main peak at 67954.5 Da indicates to naturally glycated HSA. 
Three clusters of peaks were found in fructose glycated HSA after 56 days of 
incubation at 37oC.  This hints to the heterogeneous nature of the sample resulting 
from different extents of protein glycation (Figure 3- 7).  Peaks with molecular 
masses of 65560, 67107.8 and 68560.6 Da were observed.  A similar mass 
spectrum was obtained for the glucose glycated (glucated) HSA sample.  The 
main peak at 68811 Da corresponds to the addition of around 5 glucose units 
compared to the unincubated HSA sample.  The detected masses varied from 
65579.9 to 68899.3 Da.  A significantly smaller peak was also detected at 33599.8 
Da suggesting that the protein was fragmented.  HSA samples that were incubated 
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for a shorter period of time were also analysed using nanospray MS.  After 6 and 
28 days of incubation with 50 mM glucose, the HSA mass obtained were 66821 
and 67801 Da repsectively, whilst the corresponding values for fructose incubated 
HSA were 66858 and 66866 Da.  The unincubated control HSA sample analysed 
with the same method, however, gave a mass of 66857 Da.   
 
Figure 3- 7 ESI-TOF mass spectrum of glycated HSA incubated with 50 mM fructose for 
56 days at 37oC. 
 
3.3.3 Methacrylamido phenylboronate acrylamide gel electrophoresis 
(mP-AGE) analysis of human serum albumin 
Glycated HSA has been reported to be a better glycaemic indicator than 
glycated haemoglobin, which is currently used in clinical analysis (Inaba et al., 
2007).  We, therefore, decided to focus on HSA glycation to test our newly 
developed methacrylamido phenylboronate acrylamide gel electrophoresis (mP-
AGE) system.  HSA is abundant in situ with a half-life of around 20 days.  Sugar 
incubated HSA was analysed from the first day of incubation to monitor the 
progression of protein modification.  In SDS-PAGE analysis, the profile of 
glycated HSA was identical to that of unmodified protein (Figure 3- 8), giving a 
single protein band at 66 kDa.  mP-AGE analysis, on the other hand, showed that 
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Figure 3- 10 mP-AGE analysis of 
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Figure 3- 12 mP-AGE analysis of 
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exchange program.  
 
3.3.4 mP-AGE analysis of glycated serum
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36 
.  Figure 3- 12 shows serum albumin 
oC had higher retention in the 
  Incubation with glucose 
 
glycated bovine (BSA, A), human (HSA, B) and rabbit 
-PAGE gel profile (left) and mP
erum albumin incubated at 37oC for 14 days with
), lactose (lane 3) and maltose (lane 
 
that mP-AGE can be used to examine HSA glycation, we 
band shifts in mP-AGE 
-AGE.  The retention of the 
o that described in section 3.3.3 for glycated HSA 
 
-AGE 
 100 mM: 
4).  The samples 
.  Figure 3- 13 
upon incubation 
 
 Figure 3- 13 mP-AGE analys
and mP-AGE (0.2% (w/v) MPBA, right)
at 37oC for 7 days on the left side o
incubated with: glucose (lan
galctose (lane 5) and sucrose (lane 6).
by asterisk.  
 
3.3.5 mP-AGE analysis of other proteins
Lactoglobulin 
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 under biological conditions
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 Figure 3- 14 mP-AGE analysis of 
PAGE gel profile (left)
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Figure 3- 15 15% SDS
(right) days at 37oC with: PBS buffer (lane 1), glucose (lane 2), fructose (lane 3), lactose 
(lane 4) and glucose-6-
loaded onto each lane. 
incubated sample is indicated by *.
The pasteurisation of milk takes place at high temperatures, and may result 
in different glycation products.  
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However, no glycated protein band
mP-AGE gels.    
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Figure 3- 16 SDS-PAGE analysis of 
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The effect of different sugars, metal 
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been reported to undergo autoxidation in the presence of transition metals
producing reactive oxygen species (ROS) 
amyloid peptide cross
2008, Loske et al., 2000)
binding affinity (Moudjou et al., 2007)
6) showed faster degradation
the strongest protein bands other than fresh Prp were those incubated with EDTA.  
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Figure 3- 17 mP-AGE analysis of 
with 0.2% (w/v) MPBA for 1 and 2 days’ incubation analysis 
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3.3.6 Examination of gl
Spontaneous 
recombinantly expressed proteins containing a histidine affinity tag 
et al., 1999, Yan et al., 1999b, Yan et al., 1999a)
(6PGL) is an intermediate of the pentose phosphate pathway that reacts with N
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(w/v) MPBA for 4 and 7 days’ sample incubation analysis
.  Proteins are incubation at 37oC with PBS (lane 2),
ions and EDTA (lane 5), glucose (lane 6), 
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Figure 3- 18 MS analysis of Sbi
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3.3.7 mP-AGE analysis of recombinant proteins
Using SDS-PAGE the 
from the unmodified 
the gel (Figure 3- 19)
shifted to an apparent
using 0.5% (w/v) MPBA in the gel
the freshly purified Sbi sample, as well as 
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Figure 3- 19 mP-AGE analysis 
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Figure 3- 20 mP-AGE analysis 
PAGE gel profile (left)
(A) and 3 days (B) with: PBS buffer (lane 1), gluc
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 (lane 4).  The unmodified Sbi band is around 18
 kDa in SDS-PAGE and around 50
cules.  Figure 3- 21 shows the relationship between 
mass of the gluconoylated Sbi-III-IV 
 
 Sbi-III-IV gluconoylated protein band at 
in mP-AGE analysis. 
-III-IV protein band and the retained gluconoylated 
could be detected in the western blot analysis using 
antibody.  Next we tried to establish whether
 was indeed located at the N-terminal histidine tag in 
ein.  Figure 3- 22 shows the absence of this gluconoylacted 
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 Figure 3- 22 mP-AGE analysis of Sbi
tag cleaved (lane 2) using tobacco etch virus (TEV) protease.  The gluconoyla
III-IV protein adduct (
tag is cleaved (lane 2). 
cleaved histidine tag appears (
removed by nickel-ion chelating chromato
 
3.4 Discussion 
3.4.1 Analysis of polyacrylamide gels
Dye displacement assay
The indicator displacement assay (IDA) demonstrates the ability of boronic 
acid to bind diol containing molecules
(PA) gels.  This investigation shows greater 
compared to the PA 
release information, it can be determined that specific binding 
the boronic acid and ARS
in both gels, resulting in 
balls were placed in buffer.  
colourless whilst the MPBA gel
diol interaction enabled displacement of the dye molecules 
balls on addition of fructose.
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-III-IV (lane 1) and Sbi-III-IV with histidine 
indicated with black asterisk in lane 1) is not present when the 
 A new low molecular weight band corresponding to the 
indicated with white asterisk in lane 2).  This band is 
graphy (lane 3). 
 
 
 when it is incorporated into polyacrylamide 
dye retention in the MPBA gel 
control gel (Figure 3- 3). From this data along with the dye 
took place 
 in the MPBA gel.  Non-specific interaction 
a similar amount of dye released when the stained gel 
After this washing step, the control gel was almost 
 remained orange.  The reversible 
from the MPBA gel 
   
ted Sbi-
between 
was present 
boronic acid-
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 The red coloured diol-containing Alizarin Red S (ARS) dye became orange 
in the MPBA gel, indicating a change in pH.  The gels prepared in this experiment 
were made in the presence of water instead of buffer.  The pH change in the 
buffered electrophoresis gels is negligible compared to the gel running pH.  
Addition of 0.2% (w/v) MPBA resulted in a pH alteration of 0.1 units, from 8.85 
to 8.74, whilst the running electrophoresis pH was reported to reach 9.5 
(Hachmann and Amshey, 2005).     
 
Electron Microscopy 
Electron microscopy (EM) techniques operate under high vacuum and thus 
require complete drying of samples which can result in artefact, as gels exist in a 
solvated state (Estroff et al., 2003).  Nevertheless, EM has been successfully used 
for the imaging of PA hydrogels using sample preparations of vacuum drying, 
freeze drying, critical point drying (CPD), sequential solvent dehydration and 
epoxy embedding (Hermansson and Buchheim, 1981).  These step-wise 
procedures are, however, time consuming.  CPD is often used for drying very 
fragile or wet samples without deforming or collapsing their structure (Hawkins et 
al., 2007).  
SEM was utilised to obtain detailed structure of the polyacrylamide gels 
used in this report.  Although the gel preparation procedure can result in artefacts, 
both gels with and without boronic acid should be affected in a similar way.  
Therefore, any differences in the pore structure of the gel upon boronic acid 
incorporation may be revealed.  The images in Figure 3- 4 show the gel 
microstructure, with pore size variation within each gel.  Comparisons of the gels 
with (B) and without (A) MPBA reveal analogous pore size and channel 
orientation.  Despite the random crosslinking that takes place during gel 
polymerisation, the fibres appeared to be fairly uniform.  Both PA and MPBA gel 
images show continuous homogeneous polymer strands with similar dimensioned 
pores.  It can therefore be concluded that the addition of boronic acid molecules 
does not cause significant changes to the gel structure.  
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Based on the N-phenylmethacrylamide incorporated gel (Figure 3- 11) and 
the SEM images, it can be reasoned that the separation observed between glycated 
and non-glycated proteins in mP-AGE gels is due to the boronic acid affinity of 
the affected protein sample, and not a sieving effect from the addition of the 
molecule.  The ARS displacement experiment indicated a pH change upon 
boronic acid addition.  The 0.1 pH unit modification in the PA gel is unlikely to 
cause notably difference in the protein migrational profiles as the electrophoresis 
buffer was reported to reach pH 9.5 during the electrophoresis run.     
 
3.4.2 Analysis of glycated human serum albumin  
Fluorescence spectroscopy and mass spectrometry of glycated HSA 
Fluorescence spectroscopy was utilised to determine the amount of 
fluorescent AGE products in the in vitro glycated sample.  This is however not 
equivalent to the extent of protein glycation, since not all glycation products are 
fluorescent.  Our results show that after 21 days of incubation at 37oC, HSA 
incubated with fructose contains twice as much fluorescent AGE modification 
products compared to the glucose and mannose incubated sample (Figure 3- 6), 
and maltose glycated HSA showed the least glycation product fluorescence 
intensity.      
ESI-TOF mass spectrometry of commercially obtained HSA showed that 
the native protein contains naturally modified adducts, which resulted in a 
molecular mass 1.5 kDa higher than that based on its protein sequence.  A 
theoretically highly glycated HSA sample was subsequently analysed.  After 56 
days of fructose incubation, the highest molecular weight HSA present in the 
mass spectrum is 68560.6 Da.  This corresponds to approximately three sugar 
adducts when compared to the unincubated protein.  However, the presence of 
peaks detected at a lower molecular mass than the native protein (65560 Da) 
suggests sample fragmentation.  The next cluster of peaks was found at a similar 
mass to the protein molecular weight with about 3 modifications.  Nevertheless, a 
47 
 
peak with a similar molecular mass was found in the unincubated HSA sample.  
Therefore, these peaks indicate natural protein modifications, or impurities 
present in the sample.  Similar results were obtained from the glucose incubated 
HSA, with 68811 Da as the largest peak found in the sample after 56 days of 
incubation.  Thornalley and co-workers have reported a molecular weight of 
66845 Da for minimally glycated HSA and 73226 Da for highly glycated HSA 
(Thornalley et al., 2000).  Therefore, these samples do not appear to be highly 
glycated despite the long incubation times.  It is possible that the samples started 
to degrade, or are more vulnerable to fragmentation at the end of the protein 
lifespan.  Less glycated HSA samples were also analysed.  Although the results 
hint to the progressive nature of protein glycation, similar masses were obtained 
for unincubated HSA, as well as those incubated with glucose and fructose for 6 
and 28 days.  It is suggestive that the ESI-MS analysis resulted in sample 
fragmentation, and therefore the exact number of sugar adducts cannot be 
determined.   
 
mP-AGE study 
The protein profile of all the sugar incubated HSA samples analysed by 
SDS-PAGE gels showed a single protein band corresponding to the expected 
molecular mass of the protein (Figure 3- 8).  Clearly, the small molecular mass 
increase upon the sugar addition is not detectable by conventional SDS-PAGE.   
For this purpose we transformed this analytical method by the incorporation of a 
carbohydrate affinity ligand, methacrylamido phenylboronic acid (MPBA).  We 
hypothesised that the interaction between the gel-incorporated boronic acid and 
the sugar moieties on the glycated proteins could alter protein migration during 
electrophoresis.  The migration of any unmodified proteins would remain 
unaffected.   Here we show that mP-AGE does indeed enable the separation of 
glycated proteins from unmodified ones.  The highly reproducible boronic acid 
containing gels are simple to prepare and to use (see section 3.2).  The method is 
most specific for molecules that have high boronic acid affinity.   
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Using methacrylamido phenylboronate acrylamide gel electrophoresis (mP-
AGE) for the analysis of in vitro glycated HSA reveals several features of protein 
glycation, including its progressiveness and the molecular structures formed.  At 
the initial stages of the reaction, protein bands were observed in the mP-AGE gel 
at a position expected for its molecular mass (A, Figure 3- 8).  With increasing 
incubation time, the retention of the glycated proteins in the MPBA gel increased, 
resulting in apparent higher molecular weight bands.  This effect can be explained 
by the increased number of diols in the glycated proteins available for boronic 
acid interaction.  In the same figure, an 80-kDa protein band can be observed in 
MPBA gel (indicated by B).  This band can already be seen after one day of sugar 
incubation, and corresponds to the natural protein Amadori product, since it can 
also be seen in the sample incubated in the absence of sugar.  As the glycation 
reaction progresses, this band intensifies and a new band around 90 kDa (C) 
appears (around 6 days of incubation).  There are no differences in the gel profile 
of the samples incubated with the glycation inhibitor, aminoguanidine 
hydrochloride (AGH), at this early glycation stage.  The late stage glycated 
product (shown as D) becomes visible around 40 days of sugar incubation and is 
not present in the AGH containing samples (Figure 3- 10).  It is known that AGH 
inhibits the formation of advanced glycation endproducts (AGEs) by reacting with 
oxygen radicals (Sakai et al., 2002).  There are differences in the band shifts of 
HSA samples incubated with various sugars, as seen in Figures 3- 8, 9 and 10, and 
can be explained by the Amadori products formed from the reaction with the 
different sugars, which will be discussed later in this section.   
 
Interaction between MPBA and various sugar adducts 
Sugars undergo mutarotation in solution, with the pyranose ring structure 
being the dominant species.  However, it is the linear sugar that interacts with 
protein during glycation.  As a result, sugars that are present in a high proportion 
as the linear structure are more reactive.  Aldoses are intrinsically more reactive 
than ketoses, but ketoses are reported to result in more crosslinked protein 
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aggregation.  Besides sugar reactivity, the formed adducts also differ in their 
stability.  Heyns products resulting from the fructose glycation reaction, for 
example, are more readily degraded to dicarbonyl compounds than the Amadori 
products (Figure 3- 23).  On the other hand, Amadori products are more 
susceptible to high temperatures (Corzo-Martinez et al., 2008).  Nevertheless, 
fructose is preferentially used in AGE experiments because it crosslinks proteins 
up to 10 times more rapidly than glucose (Loske et al., 2000).  It has been 
proposed that glucose became the universal metabolic fuel through evolution, 
since it has negligible effect on the formation of irreversible covalent modification 
on proteins (McPherson et al., 1988, Bunn and Higgins, 1981).   
 
Figure 3- 23 Chemical structures of Amadori and Heyns products, which are products of 
protein glycation with glucose and fructose respectively. 
The lack of retention in the MPBA gels for fructose and glucose-6-
phosphate glycated HSA samples seem to contradict previous findings showing 
they have higher glycation rates than glucose (McPherson et al., 1988, Haney and 
Bunn, 1976, Bunn and Higgins, 1981) under physiological conditions.  Fructose 
also causes larger amounts of fluorescent AGE products (Sakai et al., 2002, 
Schalkwijk et al., 2004).  This is confirmed by the results from our fluorescence 
spectroscopy analysis (Figure 3- 6) which showed a 2-fold increase in AGE 
fluorescence in the fructose incubated samples compared to those incubated with 
glucose.  Below we have formulated a model to explain the glycated HSA band 
retentions observed in mP-AGE based on the molecular interactions between 
MPBA and the respective Amadori products (Figure 3- 24).  
 Figure 3- 24 Structures of Amadori products formed during protein glycation with 
various sugars.  Glycation products of: glucose (A), fructose (B), lactose (C
phosphate (D), mannose 
with boronic acid is illustrated 
drawn in blue, while weaker 1,3 interaction 
Glucose modified protein
the cis 4,5-diol in the six
These diols are known to have strong interactions with phenylboronic acids 
(interaction shown in 
There is additional stabilisation 
50 
(E), and maltose (F). Molecular interactions of protein adduct 
on the right in dotted box.  Stronger 1,2-
is shown in orange.   
s contain an anomeric cis 1,2-diol in addition to 
-membered hemi-acetal fructosamine Amadori product.  
blue in Figure 3- 24) (Rohovec, Maschmeyer et al. 2003
from the electrostatic interaction between the 
 
), glucose-6-
diol interaction is 
).  
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protonated amino group and the negatively charged boronate moiety.  The 
combination of these favourable interactions result in a large protein band shift in 
glucose modified protein samples seen in mP-AGE. 
Glycation by fructose (fructation) proceeds via two routes (Suarez et al., 
1989), involving carbon 1 and 3 respectively.  The two resulting Amadori 
products are illustrated in Figure 3- 24.  The α-furanose structure contains an 
anomeric cis 3,4-diol, but the lack of band shift in mP-AGE suggests that the extra 
stabilisation from the boronate-amino group interaction may be hindered by the 
proximity of the C1 hydroxyl group.  The β-furanose structure contains an 
anomeric diol that forms weaker boronic acid interaction (shown in orange) along 
with a cis 4,5-diol, whereby two boronic acid molecules can interact with a single 
fructose adduct.  The alternative formation of the six-membered fructose-HSA 
may be preferentially formed.  Its 4,6-diol is only capable of forming a weaker 
six-membered cyclic ester with the gel-incorporated MPBA, which may explain 
the absence of glycated protein retention in mP-AGE. 
The lactose Amadori product contains cis 3’,4’-diol on the galactose 
moiety, as well as an anomeric diol in the glucose fragment of the molecule for 
boronic acid interaction.  The glucose moiety of the lactose adduct can also form 
the trident interaction between the diol and amine moieties and the boronic acid 
molecule as described for the glucose adduct.  These Amadori products are 
therefore expected to have similar boronic acid interaction and band shifts in the 
MPBA gels. 
Incubation of HSA with glucose-6-phosphate results in a five-membered 
furanose phosphate protein adduct that contain anomeric cis 2,3-diol.  However, 
the proximity of the phosphate group can cause steric hindrance for boronic acid 
interaction.  The phosphate group also forms electrostatic interaction with the 
amine group of protein (Sandwick et al., 2005), which may weaken the interaction 
between glucose-6-phosphate glycated HSA and MPBA further.  
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Subsequently, HSA was incubated with two more sugar molecules, 
mannose and maltose, to confirm the proposed molecular interaction model 
between glycated protein adducts and MPBA.  We envisage that since HSA 
glycated by mannose would result in an identical fructosamine adduct as glucose 
incubated protein, they would give similar band retentions in mP-AGE.  Glycation 
by maltose may also result in a similar band shift to glucose incubated samples 
because its Amadori product also contains the anomeric cis 1,2-diol, with an 
additional diol forming weaker boronic acid interaction in the second glucose 
component.  This sugar adduct will thus reveal whether the trident interaction 
between the anomeric diol and amine group with MPBA is sufficient for the 
dramatic band shifts observed.   
Figure 3- 9 shows that the protein band retention resulting from the glucose 
and mannose incubated protein is indeed identical.  Surprisingly, HSA incubated 
with maltose showed even greater protein retention than the glucose and mannose 
incubated sample, suggesting that the Amadori structure forms more favourable 
interactions with MPBA. The flexibility of the dissacharide may be accountable 
for the increased boronic acid interaction as the diols are more flexibly located on 
separate glucose moieties.  The presence of an anomeric cis diol in the presence of 
the electrostatic interaction is hence sufficient to cause the prominent glycated 
protein shifts in mP-AGE.   
The examined mP-AGE analysis is not affected by naturally glycosylated 
proteins, because both N- and O-glycan structures do not contain anomeric cis 
diols (Figure 3- 25).  The structures also tend to contain few cis diols.  Hence, 
they do not form strong boronic acid interactions, and consequently their 
migration is not affected in mP-AGE.  mP-AGE is also compatible with 
conventional gel staining methods, such as Coomassie Brilliant Blue (CBB) 
protein stain and silver staining. 
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Figure 3- 25 Example of a glycan structure (Man9GlcNAc2). 
 
Inhibitor   
mP-AGE can be used to monitor the progression of protein glycation.  
Consequently, the effects of glycation inhibitors on the in vitro glycation of 
proteins can also be assessed with this method.  Aminoguanidine was selected for 
this investigation because it was reported as a late-stage glycation inhibitor which 
does not bind the protein adduct but acts as a nucleophilic trap for the reactive 
carbonyl intermediates (Edelstein and Brownlee, 1992).  From Figure 3- 10, we 
have also established that aminoguanidine inhibits the formation of late stage 
glycation products.  However, the identity of these products and its inhibition 
mechanism cannot be determined by mP-AGE.  
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N-phenylmethacrylamide 
N-phenylmethacrylamide (NPM) is incorporated into polyacrylamide gels 
as a control for boronic acid.  Both molecules have the same chemical structure 
other than the boronic acid moiety.  Electrophoresis of heavily glycated HSA 
samples resulted only in a single protein band in the NPM incorporated gel at the 
molecular weight of protein (Figure 3- 11), similar to that obtained from SDS-
PAGE.  The glycated protein band retention observed in mP-AGE, therefore, is 
due to boronic acid interaction, and not a sieving effect from the addition of a 
small molecule in the gel.   
 
3.4.3 Analysis of glycated serum 
We subsequently tested a more complex sample, human serum, using mP-
AGE.  From Figure 3- 13, it is evident that the HSA bands shifted in the gel in a 
manner akin to those of glycated HSA described in 3.4.2.  This study therefore 
suggests that HSA is the main protein being affected by serum glycation as 
reported by Schleicher and Wieland (1989).  The glucose modified protein 
showed the most dramatic HSA band retention, followed by maltose, mannose 
and galactose incubated samples.  The bands corresponding to both the heavy and 
light immunoglobulin chains were also retained, implying that IgG too was 
glycated.  This investigation, however, highlights a limitation of mP-AGE where 
protein shifts are difficult to identify in a complex sample.  A new method to 
resolve this problem will be described in Chapter 5.  
 
3.4.4 Analysis of other proteins 
We investigated the applicability of mP-AGE in the glycation analysis of 
other proteins.  Pasteurisation of milk exposes lactoglobulin to high heat treatment 
and is therefore used to assess the effect of exogenous protein glycation.  
However, when lactoglobulin was incubated at 60oC for 1 hour with 50 mM 
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sugar, no glycated protein bands were observed in mP-AGE.  Lactoglobulin 
glycation was also investigated by subjecting the protein to longer incubation 
periods at 37oC.  Extra glycated protein bands were observed above the main 
protein band in mP-AGE after 4 days of sugar incubation.  The most apparent 
were those of glucose and lactose incubated protein, followed by glucose-6-
phosphate, and least in the fructose and PBS incubated samples (Figure 3- 14).  
This observation is in agreement with the boronic acid-sugar adduct molecular 
model proposed in section 3.4.2.  However, further glycated protein band shifts 
were not observed, even with longer protein incubation times.  Unexpectedly, 
lactoglobulin incubated with glucose appears to be most stable after 10 days of 
incubation at 37oC, followed by glucose-6-phosphate and fructose incubated 
samples.  Protein incubated with PBS and lactoglobulin was not observed in the 
SDS-PAGE gel.    
Prion proteins were examined due to its association with neurodegenerative 
disease.  Protein glycation was performed with sugars including gluconolactone, 
glucose and lactose, in the presence of copper ions and/ or metal chelator EDTA.  
The incubated protein was analysed by SDS-PAGE and mP-AGE, with similar 
protein profiles observed in both gels over a short-term incubation of 4 days 
(Figure 3- 16).  Samples incubated in the presence of gluconolactone gave the 
strongest protein bands, suggesting that this sugar may play a role in protein 
stabilisation.  In the second investigation where glucose and lactose were used in 
protein glycation, the most stable proteins appear to be those incubated in the 
presence of EDTA, with glucose affecting Prp more than lactose.   
 
3.4.5 Analysis of glycated Sbi-III-IV 
Phosphogluconoylation is common in recombinantly expressed proteins 
with a histidine affinity tag (Geoghegan et al., 1999, Yan et al., 1999b, Yan et al., 
1999a).  The 6-phosphogluconolactone (6PGL) intermediate of the pentose 
phosphate pathway is subsequently dephosphorylated to give a δ-gluconolactone 
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adduct of 178 Da.  This unwanted modification is problematic for proteins used in 
therapeutics.   
SDS-PAGE analysis of freshly purified recombinant protein Sbi-III-IV, as 
well as exogenously gluconoylated protein showed a single protein band (Figure 
3- 19).  On close inspection, a very faint band can be seen just above the main 
protein band (indicated with asterisk in the figure).  This band intensifies upon 
exogenous gluconoylation of Sbi (lanes 2 and 3) and shifted to an apparent 
position three times the molecular weight of the protein in the mP-AGE gel.  This 
glycated protein band is of the same intensity in both lanes, suggesting that all 
proteins were gluconoylated within 15 min.  Nonetheless, this band would easily 
be overlooked in SDS-PAGE due to its molecular weight similarity to the main 
protein band.  In contrast, the mP-AGE gel profile showed a dramatic retention of 
this gluconoylated protein band whilst the main protein band was identical to that 
in SDS-PAGE.  The dramatic retention of this band shift may be due to the linear 
structure of the gluconolactone adduct, which contains numerous diols that are 
capable of interacting with MPBA.  In the mP-AGE gel, the gluconoylated protein 
band was also more concentrated in the exogenously gluconoylated sample 
compared to the freshly purified control.   
When the protein was incubated over a longer period (3 days at 37oC), the 
gluconoylated protein band was absent from samples incubated with PBS and 
EDTA (Figure 3- 20).  This suggests that the gluconoylated proteins are unstable, 
and proteins incubated with gluconolactone are either stabilised or constantly 
being modified.  As expected, the retention of this gluconoylated protein band is 
proportional to the concentration of MPBA in the gel (Figure 3- 21).  
Furthermore, it was established that the modification site is at the histidine tag of 
the protein because the gluconoylated Sbi band was not observed in mP-AGE 
when the tag was cleaved (Figure 3- 22).    
The identity of the retained gluconoylated band was established using 
western blot and mass spectrometry analyses.  Both the main and the shifted 
protein bands in the MPBA gel were present in the western blot using anti-Sbi 
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antibodies.  MS of the purified protein only showed a single peak at the molecular 
weight of the protein (Figure 3- 18).  The mass spectrum of the exogenously 
gluconoylated protein, on the other hand, showed an additional peak with the 
mass increase of 178 Da, corresponding to the gluconoylated adduct.  The peak 
with a lower molecular mass results from the removal of the methionine amino 
acid at the terminus of the protein.   
Discrepancies between the glycated protein band retention of HSA and Sbi 
indicate structural differences of the adducts.  The fructosamine-HSA is a cyclic 
hemiacetal Amadori product whereas the Sbi adduct is linear, which may provide 
more flexibility for boronic acid interaction.  The significant Sbi band shift may 
also be a result of complete Sbi sample modification compared to a more 
heterogeneous glycation of HSA as a result of a large number of modifiable 
residues.   
 
3.4.6 In vivo versus in vitro protein glycation  
Sbi-III-IV and other recombinant proteins are commonly gluconoylated 
during protein production using E. coli.  However, protein glycation is often 
studied by performing in vitro glycation which involves high temperature or high 
sugar concentration to accelerate the reaction.  Despite being extensively studied, 
contradictory findings have been reported regarding the potency of the different 
sugars on the formation of glycation adducts.  This disparity could be due to 
variations in experimental procedure or sample analysis.  For example, the 
fructosamine assay is shown to be a more sensitive measure of long-term control 
than HbA1c, however unspecific reducing activity in serum not due to glycation is 
also measured (Schleicher et al., 1988).  Studies from ribose glycation showed 
AGE formation is strongly dependent on sugar concentration but independent of 
protein concentration over 1000-fold range (Booth et al., 1997).  Non-
physiological temperature and sugar concentrations enable glycation studies to be 
conducted under reasonable time-scales, but could alter the kinetics of the 
molecules and result in different glycation products.  We have also shown that 
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increasing the temperature and sugar concentrations increase the rate of glycation 
(Figure 3- 12).  The same investigation looked into the glycation rates of serum 
albumin from different organisms indicating that RSA is most vulnerable, whilst 
BSA and HSA gave similar glycated protein profile.  Nevertheless, further 
experiments are required to confirm these findings.  There have been studies 
evaluating the antioxidant activity of albumin from different animal species 
showing that human and rat albumins exhibited antioxidant activity against 
hydroxyl radicals, but bovine, rabbit, and guinea pig albumins showed weaker 
antioxidant activity (Okazaki et al., 2008).  To date, there have been few studies 
validating the effect of in vitro glycation in biological systems.  There have been 
reports of highly glycated proteins being more resistant to proteolysis (Ahmed and 
Thornalley, 2002, Oeste et al., 1987).  Nonetheless, the removal mechanism of 
aberrant aggregated protein in vivo is absent in the in vitro set-up, and may result 
in more disordered glycation at higher rates.   
 
3.5 Conclusion 
Methacrylamido phenylboronate acrylamide gel electrophoresis (mP-AGE) 
can be utilised for the study of protein glycation of a wide variety of proteins.  
This affinity based method separates glycated from unmodified proteins, and is 
not affected by naturally glycosylated proteins.  It can also be used to analyse 
complex samples, and thus has the potential to be developed into a proteomics 
tool for exploring the role of glycation in disease.  The ability to detect and 
subsequently remove gluconoylated recombinant protein is also important in the 
production of protein therapeutics.  
Increasing the concentration of MPBA incorporated into the gels result in 
greater retention of the glycated protein bands.  Nevertheless, its concentration is 
limited by its solubility in aqueous media.  Hence, optimisation of mP-AGE will 
be discussed in the next chapter in an aim to enhance the separation between 
glycated and unmodified protein.    
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Chapter 4 Improvements to the mP-AGE method 
The utilisation of methacrylamido phenylboronic acid-incorporated SDS-
PAGE gel to facilitate the separation of post-translationally glycated proteins was 
described in the previous chapter.  Here, improvements to this novel analytical 
method will be discussed.  The first modification involves ligand specific priming 
of the gel-incorporated boronic acid.  It has been hypothesised that pre-
organisation of the molecules with a template would subsequently increase their 
interaction with the analyte (Ewen and Steinke, 2008).  We therefore attempted to 
employ fructose as the template molecule for boronic acid priming, in the 
anticipation that the structure of this carbohydrate could mimic the fructosamine 
adduct and thereby pre-arrange the boronic acid incorporated in the gel.  We 
hypothesised that such a pre-arrangement could maximise the interaction between 
glucose glycated (glucated) proteins and the matrix immobilised boronic acid 
molecules during electrophoresis.  The second development utilises a layered 
boronic acid gradient gel system.  Lastly, a two-dimensional gel electrophoresis 
system is exploited to separate proteins based on their molecular mass in one 
dimension and affinity for the boronic acid in the second.  Each of these 
improvements will be examined in detail below. 
   
 4.1 Priming of mP-AGE gels 
4.1.1 Introduction  
The first example of imprinting was reported in 1949, when imprinted silica 
was used to provide more effective binding of target molecules (Dickey, 1949).  
Molecular imprinting was subsequently studied by numerous research groups due 
to ease of preparation of these highly stable materials that recognise a range of 
proteins.  The discriminatory ability makes this broad approach attractive in 
various fields including biotechnology, assays and sensors (Ansell et al., 1996, 
Mosbach and Ramstrom, 1996, Wulff, 1995, Pauling and Campbell, 1942).   The 
concept is based on the self assembly of functional monomers around a template 
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molecule in an ordered and low energy configuration, which is then polymerised.   
Such a molecularly imprinted polymer (MIP) has been reported to discriminate 
between haemoglobin HbA0 and its glycated derivative HbA1c due to the effects 
of charge and shape (Bossi et al., 2001).  Figure 4- 1 illustrates the concept of 
priming the gel-incorporated boronic acid molecules.   
 
Figure 4- 1 Schematic of the gel priming concept whereby the boronic acids are arranged 
in the presence of a template molecule.  Once polymerised, the template can be removed 
and the boronic acid molecules will be optimally positioned for subsequent interaction 
with protein sample during electrophoresis. 
 
4.1.2 Method 
Ligand-primed gels were prepared by dissolving MPBA in polyacrylamide 
solution in the presence of template molecules prior to gel polymerisation.  
Glucose and fructose were the main templates investigated in this report.  Once 
polymerised, the MPBA will be fixed in position in the gel matrix and the 
templates can be removed.  The gel can then be used in electrophoresis, with 
theoretically correctly orientated boronic acid in the gel pocket to interact with 
glycated proteins.  The process is illustrated in Figure 4- 2.  The stacking gel does 
not require template or MPBA molecules.   
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Figure 4- 2 The process of gel priming.  The boronic acid molecules interact with 
template prior to polymerisation.  Once polymerised, the boronic acid will remain in 
position even when the template is removed.  An ideal binding site is created for boronic 
acid interaction with the glycated protein sample. 
 
Mass Spectrometry analysis 
Glucose and fructose primed gels were prepared with the addition of 0.2% 
(w/v) MPBA and 0.2% (w/v) sugar in the polyacrylamide (PA) solution.  The 
polymerised gel was then electrophoresed for 30 min to simulate the sample 
analysis condition.  The resolving gel was subsequently cut into 6 pieces as shown 
in Figure 4- 3.  Slices A and B were placed in 10 ml of deionised water and 
shaken at room temperature overnight.  ESI-TOF MS analysis was subsequently 
performed on the incubating solution to determine the presence of sugar. 
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Figure 4- 3 Illustration of primed gel sections used for mass spectrometry analysis.  
Fructose and glucose primed boronic acid gels with 0.2% (w/v) MPBA and 0.2% (w/v) 
sugar were polymerised and electrophoresed for 30 min.  The gels were sliced and 
incubated in water overnight.  The solution was then analysed by ESI-TOF MS to 
determine the presence of sugars. 
 
4.1.3 Results 
4.1.3.1 Analysis of the templated gel 
Mass spectrometry  
Mass spectrometry analysis was performed to determine the presence of 
glucose and fructose templates in the primed gel after 30 min of electrophoresis.  
Fructose was present in both sections of the gel (A and B in Figure 4- 3) whereas 
glucose was only found in the lower section (B) of the primed resolving gel.  This 
analysis shows that glucose does not have the same high affinity for the boronic 
acid as fructose, and hence is removed during electrophoresis, whilst fructose 
remained bound in the primed gel.   
 
Template visualisation using Alizarin Red S  
Alizarin red S (ARS) is a dye molecule containing a cis diol moiety.  It can 
thus interact with boronic acid and act as a visualisation tool for the movement of 
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the gel template.  Unfortunately, its large molecular size alters the structure of the 
gel.  Hence, ARS incorporated gels became less rigid and required more radical 
initiators for polymerisation.  Nevertheless, the migration of ARS was monitored 
during electrophoresis to provide an insight into the movement of these templated 
molecules.  ARS was seen to travel at a similar rate to the bromophenol blue gel 
dye front during electrophoresis.  The dye appears to be slightly more retained in 
the MPBA gel than the PA one (Figure 4- 4).   
 
Figure 4- 4 ARS templated MPBA (left) and PA (right) gels after 60 min of 
electrophoresis.  More ARS molecules were retained in the MPBA gel.  
 
Boron NMR analysis of MPBA gel solution 
Nuclear magnetic resonance (NMR) spectroscopy was utilised to analyse 
the hybridisation state of MPBA.  Free boronic acids and tricoordinate esters 
resonate between 25 and 35 ppm, whilst tetracoordinate derivatives are detected 
around 10 ppm (Hall, 2005).  0.2% (w/v) MPBA in PA gel solution was prepared 
with deuterium oxide in place of water.  Samples containing 0.2% (w/v) MPBA 
with 0.2% (w/v) fructose or glucose were also prepared and analysed on Bruker 
AVANCE 300 and 11B{1H} NMR spectra recorded at 96 MHz.  The MPBA 
sample had a chemical shift of 5.72 ppm, whilst MPBA in the presence of glucose 
gave a peak at δ 6.45 ppm.  No peaks were observed in MPBA sample with 0.2% 
(w/v) fructose.  This result indicates that fructose was interacting with the boronic 
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acid molecules and disrupted the boron symmetry.  NMR was therefore recorded 
at a higher boronic acid concentration.  With 0.5% (w/v) MPBA and 0.5% (w/v) 
fructose, multiple unresolved peaks were obtained from -3 to 18 ppm.  The 
chemical shifts in all these samples indicate that the boron exists in the sp3 
hybridisation state.  Similar chemical shifts were obtained for all the samples 
analysed in Tris-glycine buffer which mimics the gel running condition.   
 
4.1.3.2 Analysis of glycated HSA using templated gel  
Glucose and fructose as template molecules 
Following the successful development of mP-AGE for glycated protein 
analysis, improvements to enhance protein separation were developed using 
molecular imprinting of the gel-incorporated MPBA with carbohydrate ligands.  
mP-AGE gels containing as little as 0.2% (w/v) boronic acid resulted in glycated 
protein band shifts.  More significant band retention was achieved when higher 
concentrations of MPBA were utilised.  However, the amount of MPBA that can 
be incorporated into polyacrylamide gels is limited by its solubility in aqueous 
media.  We attempted to overcome this drawback by employing a template to pre-
organise these MPBA molecules.    Imprinted hydrogels have been reported to 
create specificity for sugars and proteins (Hjerten et al., 1997, Parmpi and 
Kofinas, 2004, Xia et al., 2005, Uysal et al., 2008).  Some imprinted hydrogels 
were even shown to contain enzyme-like catalytic properties (Wulff, 2001).  
Fructose is the ideal template for this study because of its resemblance to the 
Amadori product formed during HSA glycation (fructosamine).  Using 0.2% 
(w/v) fructose (11 mM) with 0.2% (w/v) boronic acid (7.3 mM) in PA gel resulted 
in a similar separation between glycated and glycosylated samples as that 
obtained with 0.5% (w/v) boronic acid gel (Figure 4- 5).  In contrast, glucose used 
as the template molecule did not improve the glycated HSA mP-AGE profile.  
 Figure 4- 5 Primed mP
containing (A) 0.2% (w/v)
0.2% (w/v) fructose and (D) 
incubated at 33oC for 14 days 
3), lactose (lane 4), glucose
hydrocholoride (AGH, 
AGH (lane 8).  
To determine the optimum ratio of template to boronic acid molecul
series of experiments was
(w/v); each concentration repeated with different ratios of fruct
templates, 0 – 0.5% 
(w/v) MPBA was used with fructose to boronic acid molar ratios of 1:1, 1:2 and 
2:1.  
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Figure 4- 6 Molecular structures of the 
Structures were generated using ChemDraw
Figure 4- 7 Primed 
polyacrylamide gel containing 0.2% (w/v) MPBA and 0.2% 
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(lane 3), lactose (lane 4), glucose
hydrocholoride (AGH, lane 6), lactose with AGH (lane 7) 
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subsequently tested for their imprinting properties in 
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left to right), 0, 0.05, 0.4 and 1.6% (w/v).  (B) Graph showing the apparent molecular 
weight position of the gluconoylated Sbi protein band with 0.2% (w/v) MPBA at different 
concentrations of fructose.  As the fructose concentration increases, the retention of the 
affected protein band reduces.     
 
4.1.4 Discussion 
4.1.4.1 Analysis of primed boronic acid gel 
Mass spectrometry was used to analyse the presence of carbohydrate 
template in primed MPBA gels after 30 min of electrophoresis.  The fructose 
primed gel contains sugar throughout the gel whereas the glucose imprinted gel 
only contained sugar at the lower resolving gel section.  It was initially thought 
that the removal of templates is beneficial for sample analysis since the template-
bound boronic acid would be unavailable for protein interaction.  However, 
electrophoresis analysis of glycated HSA using glucose and fructose templated 
gels revealed better glycated protein separation in the fructose imprinted gel.  This 
indicates that the presence of fructose in the gel maintains the boronic acid 
arrangement until their interaction with protein sample.  The modified proteins 
then displace the template for boronic acid binding.  On the other hand, the 
template can also act as a competitor of the interaction between glycated proteins 
and boronic acid.   
Although the dissolved MPBA is assumed to be homogeneously dispersed 
in the PA solution, clusters of boronic acid may be present.  On addition of the 
fructose to this boronic acid solution, the BA molecules will self-assemble around 
the template and result in the even distribution of boronic acid molecules in the 
gel.  A further mechanism in which templating may result in better gel profiles is 
through the activation of the MPBA molecules.  Upon interaction with sugar, the 
pKa of MPBA is lowered.  Therefore, the boronic acids may become more 
reactive towards the analysed proteins.  NMR was utilised to investigate the 
hybridisation state of MPBA, both in the absence of sugar and in the presence of 
glucose or fructose.  The results show that the boronic acid molecules exist in the 
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sp3 hybridisation state in all three conditions.  The disrupted boron symmetry in 
the fructose templated sample indicates the presence of boronic acid-diol 
interactions.  
Alizarin Red S (ARS) was employed as a visual template to investigate the 
migration of template molecules during electrophoresis.  We found that in the 
ARS-templated gels, the orange dye migrated at the same speed as the 
bromophenol blue dye front (Figure 4- 4).  We also found that slightly more ARS 
was retained in the boronic acid gel, which may either be due to boronic acid 
interaction, or higher resistance in the boronic acid gel resulting in slower sample 
migration.  Nevertheless, incorporation of ARS affected the gel structure which in 
turn may affect ARS migration.  Templates of different molecular mass and 
charge may migrate differently to that observed with ARS.  PA gels cannot be 
imprinted owing to the lack of interaction between the template and the gel 
components.   
 
4.1.4.2 Primed gel analysis of glycated HSA 
Pre-organisation of the boronic acid with template molecules was 
hypothesised to maximise interaction between the boronic acid and protein 
samples during gel electrophoresis.  Such template molecules would require close 
molecular resemblance to the analyte of interest, have high boronic acid affinity as 
well as high solubility in aqueous media.  Nevertheless, if the boronic acid affinity 
of the template is too strong, template removal would be problematic and cause 
competition between the template and the glycated protein sample with MPBA.  
Fructose was chosen for its molecular resemblance to the fructosamine Amadori 
product, its high solubility and high boronic acid binding affinity.  
Although 0.5% (w/v) boronic acid gels gave the best protein separation, 
priming was most effective when 0.2% (w/v) boronic acid was used.  The priming 
investigation showed that various fructose template to boronic acid ratios, from 
1:3 to 3:1, all gave similar or improved glycated protein separation compared with 
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the mP-AGE method.  Imprinting with glucose, however, did not improve the 
glycated HSA separation profile.  These results indicate that addition of fructose 
enables the correct positioning of MPBA for interacting with the fructosamine 
adduct.  The enhanced glycated protein separation may also be due to activation 
of the boronic acid molecules upon template binding, thereby maintaining their 
favourable tetrahedral configuration until displacement of the fructose template by 
glycated proteins.  In contrast, interaction with glucose does not produce the same 
separation effect, either because of the removal of the glucose template during 
electrophoresis, or the incorrect pre-positioning of MPBA for glycated protein 
binding.   
Imprinting with sorbitol demonstrated the importance of the three-
dimensional sugar structure in this templating process.  Sorbitol is a linear 
molecule with cis diols that can favourably interact with MPBA, with a higher 
boronic acid affinity than glucose.  However, the glycated HSA profile was not 
improved owing to the flexibility of this linear sugar structure, resulting in a 
mixture of boronic acid arrangements.  The sorbitol diols are also in very close 
proximity to each other, and therefore, this sugar may only interact with one 
boronic acid.  Sucrose gave a slightly improved gel profile compared to mP-AGE 
that was intermediate between that of the fructose and glucose imprinted gels.  
This could be due to the presence of the glucose moiety in this glucose-fructose 
disaccharide.  In this instance, the flexibility of the disaccharide probably aided 
the positioning of the boronic acids whereby some of the pre-arranged molecules 
are in the right orientations for sample interaction. 
 
4.1.4.3 Primed gel analysis of gluconoylated Sbi 
Analysis of Sbi-III-IV by mP-AGE resulted in dramatic retention of the 
gluconoylated protein band.  We decided to re-investigate this effect using primed 
gels to determine whether the retention of the gluconoylated Sbi can be further 
enhanced.  Surprisingly, the glycated protein band showed reducing retention in 
the primed MPBA gel with increasing fructose concentrations.  This may be 
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attributable to the competition created by the fructose template.  No changes in the 
migration of this gluconoylated Sbi-III-IV band were observed in glucose 
templated MPBA gels.  This result confirms our previous observation that glucose 
is removed from the gel due to its low boronic acid affinity, or because it is easily 
displaced by the interacting protein sample.   
The extent of glycated protein separation enhancement of this imprinting 
method therefore varies, depending on the boronic acid affinity of the protein 
sample.  Protein separation may be hampered if the templates have too strong 
MPBA interactions.  The reduced glycated Sbi protein retention is an example 
where mP-AGE would be the preferred analytical technique.   
 
4.1.4.4 Boronic acid interaction with sugars in the primed gel 
Gel priming may result in the activation of the boronate ester by lowering 
its pKa (Springsteen and Wang, 2002), which alters the optimal pH for sugar 
binding (Yan et al., 2004).  Boronic acids in the tetrahedral anionic state have 
higher reactivity with diols.  However, our NMR analysis showed that the MPBA 
molecules incorporated in the PA gels exist in the sp3 hybridisation regardless of 
the presence of glucose or fructose template.  Nonetheless, during electrophoresis, 
SDS-PAGE gels can reach a pH value of 9.5 (Hachmann and Amshey, 2005).  
Under such basic conditions, phenylboronic acids would be converted into their 
charged hydrophilic form.  However, the presence of Tris molecules in the buffer 
may form Tris-borate complexes (Buchmueller and Weeks, 2004).  This 
unfavourable interaction may be eliminated in the fructose primed gel since the 
sugar templates interact with boronic acid until they are displaced by the glycated 
protein sample.  On the other hand, the presence of boronate in the gel may in turn 
favour particular isomers of fructose (Amaral et al., 2008). 
To establish the optimum template concentration, boronic acid to sugar 
interaction needs to be considered at a molecular level.  Hashidzume and 
Zimmerman (2009) proposed that each fructose reacts with two boronic acid 
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molecules that are located on opposite sides of the pore.  This interaction ratio 
was also reported by Gao et. al. (2001).  Other studies, however, have shown that 
glucose generally interacts with two boronic acid molecules whilst fructose 
prefers a 1:1 interaction, except at high boronic acid concentrations where a 1:2 
complex would be thermodynamically favoured (Rohovec et al., 2003, Kanekiyo 
and Tao, 2005, Alexeev et al., 2003).  Conversely, in the presence of large excess 
of sugar, 1:1 complexes dominate.  The environment and concentrations of buffer 
components, therefore, influence the type of complex formed.  Nevertheless, 
imprinting would not be beneficial in the formation of 1:1 complexes as the 
boronic acids would be randomly distributed in the gel in a similar manner to non-
primed mP-AGE gels.  The formation of a mixture of complexes was reported by 
Norrild and Eggert (1996) for tolylboronic acid at different sugar ratios.  We have 
therefore tested various boronic acid to template ratios to find conditions that 
resulted in the best glycated protein separation.  The results showed that similar 
glycated protein profiles were obtained using molar ratios of 1:1, 1:2 and 2:1 
fructose to boronic acid.  Nonetheless, binding affinities between boronic acid and 
fructose should be taken into consideration. 
Although imprinting can provide higher affinity and selectivity for target 
proteins, careful selection of the templates requires prior knowledge of the analyte 
structure.  Even though fructose has a complementary molecular structure to the 
fructosamine Amadori product, it does not have multiple points of interaction nor 
represent the complexity of proteins.  A fructose-amine template, using fructose 
bound lysine or arginine, would enable closer resemblance to the glycated protein 
adducts.  However, it would be difficult to separate the unreacted products and 
templating with a mixture of complexed and unreacted molecules would result in 
irreproducible priming, and difficult to evaluate protein profile.   
  
 
 4.2 MPBA gradient gels
4.2.1 Introduction 
Gradient gel electrophoresis was first described by Kolin in the mid
when this technique 
density or pH (Kolin, 1955)
sieving effect in 1967 
(Margolis and Kenrick, 1967)
for the separation of protein samples containing a large range of 
We intended to utilise the gradient gel electrophoresis 
to further improve the 
 
4.2.2 Method 
Gradient gel 
Polyacrylamide 
gradient were prepared and poured into a gradient mixer 
transferred to gel cassettes with the aid of a peristaltic pump 
polymerisation takes place. 
Figure 4- 9 Equipment s
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was used for the separation of solutions and 
.  Margolis and Kenrick then introduced the
by varying the concentrations of acrylamide and crosslinker 
.  Currently, gradient gel techniques are 
method w
separation of glycated proteins in our mP-AGE method
(PA) solutions required to generate the necessary gel 
(Gilson, Inc.
(Hoefer, Inc.
 The equipment set-up is illustrated in 
et-up for the preparation of gradient gels. 
-1950s 
proteins by 
 molecular 
mainly used 
molecular mass.  
ith the objective 
. 
) and 
) before 
Figure 4- 9. 
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Step gel 
Three solutions containing different boronic acid concentrations were 
prepared by dissolving the required amount of methacrylamido phenylboronic 
acid (MPBA) in the PA solution and polymerising them in layers as illustrated in 
Figure 4- 10.  Similarly, PA step gels were also prepared by polymerising 
different percentage PA solutions in layers. 
 
Figure 4- 10 Graphical representation of the step gel layers polymerised in the gel 
cassette for electrophoresis.  Different concentrations of PA and /or boronic acid may be 
used in the different layers.  
 
4.2.3 Results 
Gradient gels are commonly utilised in electrophoresis for studying 
complex mixtures (Walker, 2002).  Gradient gels ranging from 0.5 to 0% (w/v) 
MPBA, as well as their reverse gradient ranges were tested in our mP-AGE 
system (Figure 4- 11).  As the separation of glycated proteins was not improved in 
these MPBA gradient gels, we decided to test a layered step gel approach.   
 Figure 4- 11 Gradient gels analysing Sbi
gel (left) and 0.5 – 0% (w/v) MPBA in 5 
(lanes 1), HSA (lane 2), HSA glycated with: PBS (lane 3), glucose (lane 4) and fructose 
(lane 5), human serum (lane 6), serum incubated with: PBS (lane 7), glucose (lane 8) and 
fructose (lane 9). 
  Step gels with varying polyacrylamide and boronic acid concentrations 
were subsequently attempted
layers as shown in Figure 4
concentrations were tested in each gel layer.  The gels 
PA percentage with increasing or decreasing concentrations of MPBA
increasing or decreasing PA percentage 
MPBA concentrations in 
gels were also prepared as contr
a significantly longer
require specialised casting equipment, 
pump.   
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-III-IV, HSA and serum samples.  5 
– 20% PA gel (right) analysing: Sbi
 (Table 4 -1).  The gels were polymerised 
- 10, and different combinations of 
either contain
used in combination with 
the different gel layers.  Increasing or decreasing PA 
ol.  Although the preparation of step gels requires 
 casting time compared to gradient gels, step gels do not 
such as the gradient mixer and peristaltic 
 
– 20% PA 
-III-IV 
in three 
PA and MPBA 
ed the same 
, or an 
the varying 
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Table 4- 1 Step gel combinations of boronic acid and polyacrylamide concentrations 
investigated.  
Gel Description 
Sections of gel 
Top Middle Bottom 
PA 
(%) 
BA (% 
w/v) 
PA 
(%) 
BA (% 
w/v) 
PA 
(%) 
BA (% 
w/v) 
Increasing PA 8 0 12 0 15 0 8 0 10 0 12 0 
Decreasing PA 15 0 12 0 8 0 
Increasing BA  8 0.1 8 0.2 8 0.3 
Decreasing BA 8 0.3 8 0.2 8 0.1 
BA with increasing PA  8 0.1 12 0.1 15 0.1 8 0.2 10 0.2 12 0.2 
Increasing BA and 
decreasing PA 
15 0.1 12 0.2 8 0.3 
Decreasing BA and 
increasing PA 
8 0.3 12 0.2 15 0.1 
Increasing BA and PA 8 0.1 12 0.2 12 0.2 
Decreasing BA and PA  12 0.2 8 0.1 8 0.1 
The best protein separation was observed when 0.3-0.2-0.1% (w/v) MPBA 
was used in an 8% PA gel.  The glucated HSA samples shifted to an apparent 
molecular weight of around 100 kDa whilst those modified by fructose remained 
around 66 kDa (Figure 4- 12).  This is because the PA gel layer with the highest 
boronic acid concentration was positioned at the top of the gel, thereby enabling 
maximum boronic acid interaction with the glycated HSA samples.  Good 
glycated protein separations were also attained when 0.3-0.2-0.1% (w/v) MPBA 
was used in 8-12-15% PA gel. 
 Figure 4- 12 Step mP-AGE 
gel with polyacrylamide
the right is 8% polyacrylamide with (top to bottom) 0.3, 0.2 and 0.1% (w/v) 
Human serum albumin (HSA) 
(lane 1), glucose (lane 
sucrose (lane 6) with unincubated HSA (lane 1).
 
4.2.4 Discussion
Gradient gels were 
unmodified ones.  However, t
the separation of incubated 
could have a stacking effect which 
Subsequently, the use of 
polyacrylamide and boronic acid combinations 
with 0.3-0.2-0.1% (w/v)
separation.  HSA that 
protein band shift to a
mass when analysed in this 
solely based on its affinity 
explained by the prese
the gel allowing maximum 
unmodified proteins will 
affinity will migrate progressively faste
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gel analysis of glycated HSA.  On the left is an SDS
 concentration of (top to bottom) 8, 12 and 15%
has been incubated at 37oC for 35 days with: PBS buffer 
2), fructose (lane 3), mannose (lane 4), maltose (lane 5)
   
 
utilised to aid the separation of glycated proteins from 
he tested boronic acid gradient gels did not enhance
HSA proteins.  The gradual concentration 
counteracted the boronic acid separation 
step gels was investigated.  Within
tested in the gel layers
 boronic acid in 8% PA gel gave the best 
was incubated with glucose for 35 days at 37
n apparent position that was twice its predicted 
boronic acid step gel.  This protein band 
with the gel-incorporated boronic acid
nce of the highest boronic acid concentration at the top 
retention of glycated samples.  The migration of the 
remain unaffected.  Proteins with less boronic acid 
r in the gel as there are fewer boronic acid 
 
-PAGE 
, whilst the gel on 
MPBA.  
 and 
 
change 
effect.  
 the range of 
, the gel 
protein 
oC showed a 
molecular 
retention was 
, which can be 
of 
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molecules along the gel for interaction.  Figure 4- 12 shows that protein migration 
into the different gel layers was not hindered.  Although step gels require extra gel 
casting time, considerable improvements were obtained on analysis of glycated 
proteins.  
 
4.3 Two dimensional mP-AGE gels 
4.3.1 Introduction  
Lastly, we have utilised the concept of 2D gels to separate proteins based 
on their molecular mass (SDS-PAGE) and affinity for boronic acid (mP-AGE).  
Single and two dimensional gel electrophoreses are proteomic tools widely 
applied in the separation of proteins based on their difference in mass and charge.  
2D-PAGE is capable of resolving up to 5000 proteins (O'Farrell, 1975, Patel, 
1994).   For glycated protein analysis, the technique can be coupled to Western 
blotting, using specific antibodies raised against the Amadori product on lysine or 
its reduced hexitollysine equivalent to indicate the number of glycated proteins 
present in the sample (Matsuda et al., 1992).  Although not widely used to 
separate glycated from unmodified proteins, one and 2D gel electrophoresis have 
been used to analyse patient samples, where the level of protein glycation was 
studied in the cerebrospinal fluid from individuals with Alzheimer’s Disease 
(Shuvaev et al., 2001).  2D gels are typically used to separate complex protein 
mixtures into many more components than conventional 1D electrophoresis, by 
separating proteins on the basis of a different molecular property in each 
dimension, usually pI and molecular weight.   
 
4.3.2 Method 
A conventional SDS-PAGE gel was prepared to separate the glycated 
proteins in the first dimension and an MPBA-incorporated gel for analysis in the 
second dimension.  For the 2D gel, a thicker gel cassette (height: 100 mm × 
 width: 100 mm × thickness: 
comb for ease of loading the one dimension gel strip
protein samples in the 
the gel using a razor blade
before loading onto the 2D gel for mP
Figure 4- 13 Pictorial representation of the 2D electrophoresis 
 
4.3.3 Results 
The gluconoylated Sbi protein was 
electrophoresis methodology 
were electrophoresed
(w/v) boronic acid gel
observed in the first po
apparent molecular weight of 
interaction with the gel
however, remained on the diagonal
dimension (Figure 4-
enables the identification of all 
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1.50 mm; Invitrogen) was used along 
.  After separation of the 
first dimension, the protein sample lane wa
, and subsequently soaked in sample buffer for 10 min 
-AGE analysis (Figure 4- 13
 
gel set-up.
once again analysed 
because of its high affinity for MPBA
 in a 15% polyacrylamide gel (1D) and subsequently in
 (2D).  Although the gluconoylated band 
lyacrylamide dimension as expected, it had
around 60 kDa in the second dimension 
-incorporated boronic acid.  The unmodified protein bands
 since they migrated to the same exte
 14).  With these results, we show that this simple technique 
the glycated proteins present in the sample.  
with a 2D gel 
s excised from 
). 
 
with the 2D 
.  The samples 
 0.5% 
could not be 
 shifted to an 
due to 
, 
nt in each 
 
 Figure 4- 14 Two dimensional 
separation is based on 
dimension separation is based on mP
incubated at 37oC with gluconolactone 
 
4.3.4 Discussion
2D gel electrophoresis separates proteins based on different properties, 
typically pI using isoelectr
PAGE.  In this study,
and mP-AGE in the second dimension
their molecular mass and 
proteins are expected to be retained in their electrophoretic mobility 
dimension whilst unmodified proteins 
4- 14 demonstrates that 
is comparable to that of 
found on the diagonal.  
proteins even in complex sample
the gel.   
It is possible to use boronic acid gradient in the 
potential of this technique 
proteomic analysis, which can separate 
Regrettably, this option was not investigated due to the 
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mP-AGE analysis of Sbi-III-IV.  The f
SDS-PAGE using 15% polyacrylamide gel (left) and the second 
-AGE using 0.5% (w/v) MPBA (right).  Sbi has been 
for 15 min. 
 
ic focussing (IEF) and molecular weight using SDS
 SDS-PAGE analysis was performed in the first dimensio
.  Proteins were first separated according to 
secondly by their boronic acid affinity
remain on the diagonal of the gel.  
the retention of the gluconoylated Sbi-III-
mP-AGE, whilst the unmodified protein bands 
This 2D method enables easy identification of 
 mixtures, based on their off-diagonal position in 
2D gel.  However, t
lies with the combination of IEF and 
vast array of proteins 
lack of suitable
 
irst dimensional 
-
n, 
.  Glycated 
in the second 
Figure 
IV protein band 
can be 
glycated 
he 
mP-AGE for 
in a single gel.  
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equipment.  Nonetheless, this system may be limited by the operational pH of the 
boronic acid molecules.   
 
4.4 Conclusion of mP-AGE optimisation techniques 
This chapter discussed various optimisation techniques that can be applied 
to mP-AGE to enhance glycated protein separation.  The first part of this chapter 
described the application of priming the gel-incorporated boronic acid using a 
carbohydrate template.   Pre-organisation of MPBA using fructose as the template 
was analysed with glycated HSA samples and showed improved separation 
between glycated and unmodified proteins.  In addition to the positioning of 
boronic acid molecules, priming may also activate the MPBA by altering its 
complexation pKa and binding affinities.  NMR analysis showed that MPBA 
exists in its sp3 hybridised configuration in the gel, regardless of the presence of 
bound carbohydrates.  The tetrahedral anionic boronic acid should form more 
favourable diol interactions than its trigonal neutral form.  On the other hand, 
templating may simply result in more even distribution of the MPBA molecules 
throughout the gel matrix, rather than the chance of forming boronic acid clusters.  
However, prior knowledge regarding the analyte is required for template 
selection, which should not have too high boronic acid affinity as it would create 
competition with the protein sample.   
In the second part of this chapter the utilisation of gradient and step gels 
was discussed.  Although gradient gels did not result in the desired separation 
effect, the corresponding step gels showed promising enhancements to the 
separation of glycated proteins.  Finally, 2D gels were investigated because of 
their application in proteomic analysis of complex samples.  When glycated 
proteins were analysed using SDS-PAGE in the first dimension followed by mP-
AGE separation in the second dimension, we found that while all the unmodified 
proteins accumulated at the diagonal of the gel, the carbohydrate modified 
proteins with boronic acid affinity were retained at positions above the diagonal in 
the gel.  All these methods provide an improvement to the analysis of glycated 
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proteins.  An alternative approach would be to design and synthesise more water 
soluble boronic acid compounds.  Nonetheless, these improvements lowered the 
cost of mP-AGE, as less boronic acid was needed to give the same extent of 
glycated protein separation.  In the next chapter I will address the visualisation of 
glycated proteins with the aid of fluorescent boronic acid.    
 
 
  
 Chapter 5 Fluorescence im
5.1 Introduction  
Fluorescence technology 
in both in vivo and 
fluorescent saccharide sensor,
acids (Yoon and Czarnik, 1992)
utilisation of fluorophore attached 
sugars (Moschou et al., 2004, Nishiyabu et al., 2010b)
example of a fluorophore
photoinduced electron tran
proximity to the boronic acid 
the use of hexamethylene linker between two boronic acid moieties 
favour the binding of glucose.  However, 
associated with such 
PET glucose sensing system
solutions (Moschou et al., 2004)
Figure 5- 1 Design of a photoinduced electron transfer (PET) 
In this chapter, a
the visualisation of glycated proteins 
boronic acids are capable of 
hypothesise that fluorescent boronic acids 
glycated proteins, and enable their visualisation without protein staining.  This 
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aging of glycated proteins 
has been used as a sensing and visualisation 
in vitro assays.  Yoon and Czarnik reported the first 
 which was based on fluorophore-appended boronic 
.  Recently, there has been great interest in 
boronic acids as reporters for various 
.  Figure 5
-linked phenylboronic acid that has been designed for a 
sfer (PET) sensing system.  The amine group at close 
enables sensing at physiological pH.  
there are still various 
fluorescence sensing techniques.  Compounds used in the 
, for example, have limited solubility in aqueous 
.  
fluorescent boronic acid.
 fluorophore-conjugated boronic acid was investigated for 
analysed by gel electrophoresis.  Sin
binding sugar moieties of glycated proteins, 
can be utilised to selectively label 
tool 
the 
ions and 
- 1 shows an 
In addition, 
is reported to 
drawbacks 
 
 
ce 
we 
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method will thus simplify the gel profile of complex protein samples by 
eliminating the detection of non-glycated proteins in the sample.  Fluorescence 
labelling also allows instantaneous post electrophoresis visualisation of the 
affected proteins without protein staining.  
 
5.2 Method 
Fluorescein-boronic acid, 4-(3-(3-boronophenyl)thioureido)-2-(6-hydroxy-
3-oxo-3H-xanthen-9-yl)benzoic acid (Fl-BA, Figure 5- 2), was synthesised as 
previously reported (Elfeky et al., 2010) and was supplied by Dr Tony James’ 
group at Department of Chemistry at the University of Bath.  Serum samples were 
incubated with 10 mM Fl-BA at room temperature for 30 min.  The samples were 
diluted ten-fold with PBS before electrophoresis analysis.  Fl-BA labelled samples 
were then visualised using AlphaImager 3400 UV transilluminator (Alpha 
Innotech) after the electrophoresis run using long wavelength UV light (342 nm) 
and an ethidium bromide (595 nm) or green filter (537 nm).  Contrast has been 
optimised in the gel images. 
 
Figure 5- 2 Fluorescein boronic acid, 4-(3-(3-boronophenyl)thioureido)-2-(6-hydroxy-3-
oxo-3H-xanthen-9-yl)benzoic acid (Fl-BA), used to label glycated proteins analysed by 
gel electrophoresis. 
 5.3 Results 
The use of fluorescence for the
complex human serum
labelled serum samples 
5- 3) and visualised 
fluorescent band was observed in the UV image of the 
weight corresponding to that of HSA.  However, two fluorescent bands can be 
seen in the MPBA gel, indicating the presence of HSA molecules 
glycation levels.  When the gels were subsequently stained with 
numerous proteins can be seen in 
MPBA gel, showing the presence of glycated proteins in the sample.  
Figure 5- 3 Fluorescein
15% PA, A) and step MPBA gel (
under UV prior to protein staining.  
Coomassie stained gel 
split into two in MPBA gel, with the upper band 
because of higher gel retention and higher fluorescence
concentration. 
Subsequently, 
Fl-BA and analysed
regardless of their carbohydrate 
differences were observed between 
in the mP-AGE gels
Chapter 3.  Figure 5-
A 
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 visualisation of glycated proteins in a 
 sample was examined.  Fluorescein-boronic acid 
were analysed on SDS-PAGE and mP-AGE
with UV light prior to protein staining.  
PA gel, with a molecular 
Coomassie 
both gels, some of the bands have
-boronic acid (Fl-BA) labelled human serum.  Step PA gel (
0.3-0.2-0.1% (w/v) MPBA in 8% PA, 
The fluorescent image is shown on right and 
on the left.  A single HSA band is present in PA gel.  This band is 
corresponding to more glycated protein 
 intensity despite 
in vitro glycated human serum samples were 
.  In the SDS-PAGE gels, serum profiles were identical 
incubation time.  On the other hand, d
serum samples incubated with dif
.  This observation has already been discussed 
 4 shows the serum profile obtained in MPBA gels 
B 
(Fl-BA) 
 gels (Figure 
Only a single 
with different 
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 shifted in the 
  
 
8-12-
B) was visualised 
the lower protein 
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ramatic 
ferent sugars 
in detail in 
after 7 
 and 10 days of sugar 
in all the samples corresponds to HSA.  
Coomassie stained gel, 
molecular mass position of around 100 kDa.  
and mannose showed similar band 
revealed almost no retention
comparable to those 
Chapter 3. 
Figure 5- 4 Fluorescent image of glycated serum samples.
gel with glycated serum samples incubated 
fructose (lane 2), mannose
6).  Lanes 7 to 12 are serum incubated 
serum (lane F).  The samples have been labell
and visualised by UV (left) prior to protein staining with Coomassie blue (right).
From the figure, it 
affinities for different
band showed a lower level of 
glucose and mannose glycated samples.  In addition to 
protein adducts resulting from 
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86 
incubation at 37oC.  The highest fluorescence intensity 
In both the fluorescent image and the 
glucated HSA bands shifted to an apparent
 Samples incubated 
shifts, whereas the fructose modified sample 
 of the 66 kDa HSA band.  These 
observed in the glycated HSA samples that are described
  0.2% (w/v) MPBA in 10% PA 
at 37oC for 7 days with: 
 (lane 3), maltose (lane 4), galactose (lane 5) 
with the respective sugars for 10 days
ed with fluorescent boroni
can be seen that Fl-BA, like MPBA, also 
 glycated Amadori products.  The fructose incubated 
fluorescence intensity when compared to the 
differentiat
different sugars, this visualisation method
the extent of protein glycation.  Higher fluorescent 
samples with longer sugar incubation times.
 gel electrophoresis parameters 
containing fluorescein-boronic acid 
background fluorescence, which may be 
the fluorescent boronic acid and Tris molecules present in 
band 
 higher 
with maltose 
results are 
 in 
 
glucose (lane 1), 
and sucrose (lane 
, with fresh 
c acid (Fl-BA) 
 
has different 
protein 
ing between 
 also 
 
(Fl-
due to 
87 
 
the gel buffers.  Different buffer systems were therefore examined in an attempt to 
eradicate this problem (Table 5 -1).  These experiments utilised common buffers, 
as well as those previously analysed by McLellan for use in electrophoresis 
(1982).  The chemical structure of the buffer components are shown in Figure 5- 
5.  The electrophoresis migration times and protein profiles were used to assess 
the suitability of these buffer systems.  MPBA was not incorporated into these 
gels due to the possible competition between MPBA and Fl-BA for the interaction 
with glycated protein samples. 
 
 
Figure 5- 5 Chemical structures of the buffer components investigated for gel 
electrophoresis.    
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Table 5- 1 Buffer systems investigated for the analysis of diabetic patient serum samples 
labelled with fluorescein-boronic acid (Fl-BA). 
Buffer 
system 
Stacking gel  
buffer 
Resolving gel 
buffer Running buffer 
1 0.5 M Tris pH 6.8 1.5 M Tris pH 8.8 
(8% PA) 
25 mM Tris, 190 mM 
glycine, 0.1% SDS pH 8.3 
2 0.5 M Tris pH 6.8 1.5 M Tris pH 8.8 
(8% PA) 
25 mM Tris, 60 mM 
glycine, 0.1% SDS pH 8.7 
3 0.5 M Tris HCl pH 
7.5 
1.5 M Tris HCl pH 
8.1 (10% PA) 
25 mM Tris, 190 mM 
glycine, 0.1% SDS pH 8.3 
    
4 Precast Bis-tris Precast Bis-tris 
(10% PA) 
50 mM MOPS (salt), 50 
mM Tris, 0.1% SDS, 1 
mM EDTA pH 7.8 
5 Precast Bis-tris Precast Bis-tris 
(10% PA) 
50 mM MOPS (acid), 50 
mM Tris, 0.1% SDS, 1 
mM EDTA pH 7.6 
6 Precast Bis-tris Precast Bis-tris 
(10% PA) 
50 mM MES (acid), 50 
mM Tris, 0.1% SDS, 1 
mM EDTA pH 7.4 
7 Precast Bis-tris Precast Bis-tris 
(10% PA) 
25 mM Tris, 190 mM 
glycine, 0.1% SDS pH 8.3 
    
8 0.5 M gly-gly pH 
6.8 
1.5 M gly-gly pH 8.8 
(12% PA) 
25 mM Tris, 190 mM 
glycine, 0.1% SDS pH 8.3 
9 0.5 M gly-gly pH 
7.5 
1.5 M gly-gly pH 8.4 
(10% PA) 
50 mM gly-gly, 50 mM 
Tris, 0.1% SDS, 1 mM 
EDTA pH 8.3 
    
10 0.5 M Tricine pH 
7.0 
1.5 M Tricine pH 7.0 
(10% PA) 
25 mM Tris, 190 mM 
glycine, 0.1% SDS pH 8.3 
11 0.5 M Tricine pH 
7.1 
1.5 M Tricine pH 8.0 
(10% PA) 
25 mM Tris, 190 mM 
glycine, 0.1% SDS pH 8.3 
    
12 0.5 M MOPS pH 
5.9 
1.5 M MOPS pH 7.5 
(8% PA) 
60 mM MOPS, 40 mM 
glycine, 0.1% SDS pH 7.4 
13 0.5  M HEPES pH 
10.9 
1.5 M HEPES pH 
11.3 (10% PA) 
25 mM Tris, 190 mM 
glycine, 0.1% SDS pH 8.3 
14 100 mM Histidine, 
120 mM MOPS pH 
6.4 
240 mM Tris, 80 
mM boric acid pH 
8.9 (8% PA) 
40 mM Tris, 20 mM boric 
acid pH 8.6 
 
In Table 5- 1, buffer system 1 is the commonly used Laemmli system and, 
as mentioned above, suffers from background fluorescence due to the presence of 
Tris molecules.  Decreasing the glycine concentration from 190 to 60 mM 
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resulted in similar sample running and resolutions (buffer system 2).  However, 
when Tris HCl was used instead of Tris base in the preparation of polyacrylamide 
gels, the gel run times increased but the sample resolution was still acceptable.  
Systems 4 to 7 used precast Bis-tris gels (Invitrogen) which gave good sample 
resolution when MES and MOPS buffers were used.  However, the samples were 
not well resolved with Tris buffer.  The gels generally require longer running 
times compared with the Laemmli system.  Similar sample resolution was 
achieved when gels were cast with 0.5 M Bis-tris pH 6.8 in the stacking gel, and 
1.5 M Bis-tris pH 7.5 for the resolving gel.  50 mM MOPS or MES (acid) and 50 
mM Tris with 0.1% SDS and 1 mM EDTA pH 7.6 was used as the running buffer.  
When 0.5 M Bis-tris pH 6.8 was used in both the stacking and resolving gel, 
samples were not sufficiently stacked.  Conditions 8 and 9 gave adequate sample 
resolution and gel run time of an hour.  Buffer 10 did not result in good sample 
resolution, but systems 11 to 14 all gave good resolution and reasonable run 
times.  Nevertheless, the detection of small molecular weight proteins might be 
hindered by the presence of high fluorescent intensity from the excess Fl-BA that 
migrate at the bottom of the gel. 
 
5.5 Discussion 
5.5.1 Fluorescent boronic acid labelling of glycated sample 
Protein band shifts of complex samples are difficult to identify in 1D gels, 
such as those of glycated HSA in serum shown in Figure 5- 3.  In the last chapter, 
we tried to resolve this problem with the use of 2D mP-AGE gels.  In this chapter, 
we attempted to fluorescently label glycated protein samples using fluorophore-
appended boronic acids.  This method should work with any fluorescent boronic 
acid molecules, although their fluorescence intensity, analyte selectivity and 
electrophoresis migration might differ.   
Fluorophore-appended boronic acid labelling was employed for the 
selective identification of glycated proteins and to enable their visualisation in 
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complex samples.   After electrophoresis, the labelled protein bands were 
visualised using a standard UV gel imager and fluorescent images recorded prior 
to protein staining.  Samples have to be labelled with the Fl-BA before 
electrophoresis because post-run staining of the gel would result in an entirely 
fluorescent gel.  Figure 5- 3 demonstrates the ability of this technique to identify 
low concentrations of naturally glycated proteins.  Migration of proteins during 
electrophoresis was not affected.   Excess Fl-BA was utilised in the investigation 
to ensure sufficient labelling of the target proteins, as any unbound fluorescent 
label would be removed during electrophoresis.  Fluorescence of small molecular 
weight proteins that migrate close to the bromophenol blue dye front might be 
hindered by the fluorescence of this excess Fl-BA label.   
Noticeable differences in the HSA protein band between SDS-PAGE and 
mP-AGE gels were observed in Figure 5- 3.  The single fluorescent HSA band 
present in the PA gel has split into two bands in the MPBA-incorporated gel, 
presumably corresponding to their different levels of protein glycation.  The HSA 
band that was retained at a higher molecular weight position not only has higher 
MPBA affinity, it also has higher fluorescent intensity than the lower band, when 
compared to their protein concentration as based on their Coomassie staining 
intensity.  This method, therefore, simplifies the gel profile by highlighting only 
the glycated proteins.   
Glycated human serum samples incubated with different sugars were also 
examined (Figure 5- 4).  In the fluorescent image, samples that have been 
incubated for 10 days have higher fluorescent intensity than their counterparts 
which were only incubated for 7 days.  This observation shows the progressive 
nature of glycation, and more importantly the possibility to quantify the level of 
glycation using this fluorescent labelling method.  Differences in sample 
migration in mP-AGE upon HSA glycation with different sugars were caused by 
their affinity for the gel-incorporated boronic acid (Chapter 3).  In a similar 
manner, these glycation products also have different affinities for the Fl-BA.  The 
glucose and mannose incubated sample show higher fluorescence intensity when 
compared to the fructose incubated protein, which may be caused by the 
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molecular interactions between boronic acid and sugar adducts explained in 
Figure 3- 24.  However, analysis of Fl-BA labelled sample in mP-AGE may result 
in competition between the gel-incorporated MPBA and Fl-BA for the glycated 
proteins.  This competition may affect sample fluorescence intensity as well as 
protein band retention.  Nevertheless, Figure 5- 4 shows that sufficient sample 
labelling can be achieved along with significant protein band shifts when Fl-BA 
labelled human serum samples were analysed in mP-AGE.   
 
5.5.2 Electrophoresis buffer investigation 
To maximise the effect of protein visualisation using fluorescent boronic 
acid, an investigation was carried out to formulate a new buffer system without cis 
diol moieties to eliminate any unwanted boronic acid interaction with buffer 
components.   
 
Electrophoresis buffer systems 
A buffered solution consists of a weak acid and its conjugated base.  In 
electrophoresis, the main function of the buffer is to maintain the pH of the gel, 
thereby preventing damage to sample molecules.  An ideal buffer has a pKa very 
close to the desired pH to maximise buffering capacity.  As most proteins have 
isoelectric points below 7.5, they are best separated in slightly alkaline conditions 
(pH 8 – 9).  Thus, the most suitable electrophoretic buffers have pKa in the range 
of pH 7 to 9 (Equation 5- 1).   
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Equation 5- 1 The Henderson Hasselbalch equation summarising the relationship 
between pH and pKa. 
Since buffer ions carry most of the current through the electrophoresis gel, 
their ionic strength must be sufficient to keep the sample in solution and provide 
enough buffering capacity.  Although high concentrations of the gel buffer slow 
sample diffusion and create sharp bands, they also generate high electrical 
conductivity.  Buffers that form ions with high charges yield high ionic strength 
without high buffering capacity.  As a result, at relatively low concentrations of 
this buffer, the gel conduct too much current, with ions moving quickly through 
the gel and depleting the buffer of ions.  On the other hand, buffers that are 
uncharged at the desired pH have low electrophoretic mobility thereby allowing 
high concentrations to be employed for buffering capacity and sample stability 
without producing unacceptably high conductivity (Garfin, 2003).   
 
How electrophoresis works 
The most commonly used buffer for electrophoresis is Tris, with Bis-tris 
and Tricine being the more recently used alternatives.  In Ornstein and Davis 
system, Tris-HCl is utilised in both the sample and gel buffer, with stacking gel at 
pH 6.8 and resolving gel at pH 8.8.  Tris-glycine is used as the electrode reservoir 
buffer.  When electrophoresis is initiated, glycine has low mobility owing to weak 
ionisation whilst chloride is highly mobile because of complete ionisation.  The 
mobility of protein is intermediate between that of the trailing ion, glycine, and 
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the leading ion, chloride.  This set-up results in the stacking of samples.  When 
glycine enters the higher pH resolving gel, it becomes more negatively charged 
and increases in mobility, overtaking the proteins and migrates behind the 
chloride ions.  The proteins are then sieved in the higher percentage resolving gel 
(Ornstein, 1964, Davis, 1964, Laemmli, 1970).  The speed of the moving 
boundary therefore depends on the pH of the gel, and properties of leading and 
trailing ions such as pKa and intrinsic mobility.  Buffer ions are not sieved by the 
matrix, so their migration rates are determined solely by their charge to mass 
ratio. 
 
Exploring alternative electrophoresis buffer systems 
Although Fl-BA efficiently labels glycated samples and enables their post-
electrophoresis visualisation, unwanted fluorescence background can interfere 
with band recognition, especially with low fluorescent intensity bands.  Therefore, 
a variety of buffer systems was investigated to determine their usability for this 
technique.  Our results indicate that Bis-tris may be a suitable alternative buffer 
system.  Although Bis-tris consists of a diol moiety, the free amine group present 
in Tris is eliminated which results in less boronic acid affinity and hence less 
fluorescence background.  Other acceptable buffer systems include MOPS, 
HEPES and gly-gly, although the concentration of the buffer components needs to 
be carefully assessed for best electrophoretic separation of protein samples.  
Fluorescent inhibitors were also utilised in an attempt to minimise the fluorescent 
background, but were not effective.  This may be due to the excess amount of Fl-
BA utilised in the experiment.  Therefore, this technique would benefit greatly 
from the development of more sensitive and selective fluorescent boronic acid 
compounds.  
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5.6 Conclusion 
In this chapter, we have reported a method for the selective labelling of 
glycated proteins that enable their visualisation in a complex sample prior to 
protein staining.  This method, like mP-AGE, has specificity towards different 
Amadori products and can be used as a semi-quantitative analysis for the 
determination of the amount of glycated proteins present in the sample.   
Nevertheless, unwanted fluorescence background was observed in gels using the 
Laemmli buffer system owing to the presence of diol-containing buffer 
component, Tris.  Analysis of other gel systems identified Bis-tris as a suitable 
alternative.  However, the visualisation of small molecular weight protein was 
obstructed with excess Fl-BA label.  The development of more sensitive 
fluorescent boronic acid compounds would eliminate some of these draw-backs, 
and are part of the on-going work in our laboratory.  This technique has great 
potential as a proteomics tool, as the identification of modified proteins is often 
challenging in complex biological samples. 
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Chapter 6 Applications of mP-AGE in disease models 
6.1 Introduction 
Thus far, we have reported the use of mP-AGE in the analysis of in vitro 
glycated protein and complex biological samples.  In this chapter, disease models 
including diabetic patient serum and Alzheimer’s Disease transgenic mouse brain 
homogenates are examined with the newly developed mP-AGE techniques and 
fluorescent boronic acid labelling.     
 
Diabetes 
Diabetes mellitus is the most prevalent global metabolic syndrome (Hudson 
et al., 2002).  Over 55 million people in Europe have diabetes in 2010.  This 
figure is estimated to touch 66 million by 2030 (Unwin et al., 2009).  This disease 
and its long-term complications such as neuropathy, nephropathy and retinopathy 
utilises about 8% of the UK National Health Service (NHS) budget (Home et al., 
1999).  Normal blood glucose level is around 100 mg/dl, but diabetic patients can 
have glucose levels of 200 to 300 mg/dl.  Stirrban and Tschoepe (2008) have 
reported that even people with uncomplicated diabetes have 30% higher AGE 
concentration than their non-diabetic counterparts.  Advanced glycation 
endproducts (AGEs) are associated with diabetic microvascular complications 
(Makita et al., 1991).  AGEs exert their effect through interaction with receptor 
for AGE (RAGE).  Upregulated RAGE induces a cascade of cytotoxic pathways 
(Hudson et al., 2002).  
Glycated haemoglobin, HbA1c, is currently used as the clinical disease 
marker for diabetes.  However, various reports have suggested HSA to be a better 
glycaemic indicator (Inaba et al., 2007).  There have also been reports linking 
diabetes and Alzheimer’s Disease, both of which are associated with AGE and 
increased oxidative stress (Ott et al., 1999).   
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Alzheimer’s disease 
Alzheimer’s Disease (AD) was named after Alois Alzheimer, who in 1906 
suggested an association between abnormal amyloid deposits in the brain and 
dementia.  It is an incurable degenerative condition characterised by cognitive 
decline associated with neuronal loss and brain pathological lesions.  The ageing 
population of the developed world creates an increasing socioeconomic burden 
from neurodegenerative diseases.  Approximately 85% of AD cases are late-onset, 
sporadic form that lack hereditary links but are associated with oxidative stress 
(Selkoe, 2001, Mathias, 2006, Behl, 1999).  Increased AGE are accumulated in 
the senile plaques of Alzheimer’s patients (Vitek et al., 1994), with a small 
percentage of plaques found to be AGE positive but negative in β amyloid 
(Srikanth et al., 2011). 
 
6.2 Materials and Methods 
6.2.1 Disease model samples 
Diabetic patient serum samples were obtained from Sunnylab.  The 
patients have been diagnosed with type I diabetes mellitus with glutamic acid 
dehydrogenase (GAD) and insulin autoimmune antibodies (IAA and IA-2) as 
markers. 
Brain homogenates from Alzheimer’s Disease transgenic mouse model 
with APP double mutant were analysed, along with wildtype control (supplied by 
Robert Williams at Department of Biology and Biochemistry at the University of 
Bath).  The transgenic AD mouse expresses amyloid β (Aβ) plaque pathology 
(TASTPM) but does not exhibit the characteristic behavioural impairment 
(Howlett et al., 2004).  Brain homogenates were prepared from the cortex and 
cerebellum of 5-month old heterozygote transgenic mice over-expressing both 
hAPP695swe mutation and presenilin-1 M146V mutation (TASTPM) (Howlett et 
al., 2004), and the cortex of age-matched wild type C57BL/6 as control.  The 
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brain sections provided by GlaxoSmithKline were mechanically homogenised in 
0.5 ml of Tris EDTA buffer with protease inhibitor, and spun at 2,000 x g for 5 
min to get crude homogenates.  
 
6.2.2 Mass Spectrometry analysis 
 Protein bands of AD transgenic mouse brain homogenates were excised 
from polyacrylamide gels and analysed by MS at the University of the West of 
England.  MALDI-TOF analysis was carried out after in-gel trypsin digestion.  
The digested protein produced unique peptide mass fingerprints (PMF) which 
were compared to those in the SwissProt database. 
 
6.3 Results 
6.3.1 Diabetic patient serum analysis 
Diabetic patient serum was fluorescently labelled with fluorescein (Fl) and 
fluorescein-boronic acid (Fl-BA), and subsequently analysed by SDS-PAGE.   
Although 30 min of sample incubation with the fluorescent label (Fl-BA) resulted 
in sufficient fluorescence intensity for the visualisation of glycated protein bands, 
longer incubation time resulted in higher fluorescence intensity (Figure 6- 1).  The 
optimal length of sample labelling, therefore, depends on the stability of the 
protein.   
 Figure 6- 1 Investigation of diabetic serum samples labelled with fluorescein
(Fl-BA) for different lengths of time on 8% PA gel.  Serum sample was incubated with 
Fl-BA at room temperature for 15 min (lane 1), 30 min (lane 2), 1 h (lane 3), 2 h (lane 4) 
and 20 h (lane 5).  The gel is visualised by UV (left, long wavelength 365 nm with orange 
filter exposed for 0.2 s) prior to protein staining (right).
Figure 6- 2 sho
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6.4 Discussion 
6.4.1 Diabetic patient serum analysis 
Figure 6- 1 investigated the fluorescence intensity of protein bands at 
varying lengths of fluorescent labelling at room temperature.  Although longer 
incubation time resulted in higher fluorescence intensity, we have used 30 min 
sample labelling in subsequent analysis to minimise protein degradation.  
Fluorescence labelling could be carried out at 4oC over a longer period of time for 
unstable proteins although this alternative was not investigated.   
The protein profiles of normal human serum and those of diabetic patients 
were almost identical in SDS-PAGE and mP-AGE.  Figure 6- 2 compares the 
fluorescent protein profiles of diabetic serum samples labelled with fluorescein 
(Fl) and boronic acid-appended fluorescein (Fl-BA).  The faint fluorescent HSA 
band observed in the Fl labelled samples may be due to unspecific binding of Fl, 
or more likely a result of fluorescent-AGE because the intensity is higher in 
diabetic samples.  The same samples gave much higher fluorescent intensity 
bands when labelled with Fl-BA.  However, there was also more fluorescence 
background in these Fl-BA labelled sample lanes compared to Fl labelled ones, 
suggesting interaction between Fl-BA and diols present in the gel buffer, such as 
Tris. 
Figure 6- 2 shows that the HSA band (around 60 kDa) in diabetic patient 
serum of lane 8 has the highest fluorescent intensity whilst the lower protein band 
around 50 kDa is brightest in the lane 9 sample.  The reason for the discrepancy is 
undetermined.  The lower fluorescence band could be IgG heavy chain, although 
further analysis, such as MS, is required for its identification.  In order to 
determine the correlation between protein glycation and the observed fluorescent 
band intensity, additional sample information such as the patients’ glycaemic 
control is required.   
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Using a fluorescence scanner would enable quantification of these 
fluorescent band intensities.  It is sensitive and can detect very low fluorescent 
values.  Future investigation will focus on the quantification of the fluorescence 
intensities of the labelled bands using this technique. 
 
6.4.2 Alzheimer’s Disease mouse brain analysis 
Alzheimer’s Disease (AD) transgenic mouse brain homogenates were 
analysed with 2D mP-AGE with Fl-BA labelling to determine the effectiveness of 
mP-AGE techniques in the detection of disease markers.  The samples were 
analysed by SDS-PAGE in the first dimension followed by 2D mP-AGE analysis 
to identify the presence of glycated proteins.  From Figure 6- 4, it can be 
determined that all the samples contained some affected proteins but the extent is 
more marked in the AD samples (B and C).   
Fluorescence analysis was then utilised to simplify the protein profile by 
highlighting only the glycated proteins.  Figure 6- 5 shows a number of distinct 
bands present in the TASTPM mouse sample, compared to a single clear band 
around 120 kDa for the wildtype sample.  Some of the fluorescent bands found in 
the AD mouse sample do not correspond to major proteins in the stained gel 
implying that this technique does not label abundant proteins in the sample but 
those that are glycated.   
Subsequently, 2D gels were run to enhance the separation of these 
fluorescent bands, which were excised and further analysed by MS for protein 
identification.  The brightest band in Figure 6- 6 (indicated as E) corresponds to 
haemoglobin, which is a known glycation marker for diabetes.  It may also be 
associated with AD due to its link with oxidative stress.  Bands A and B in the 
figure were identified as 14-3-3 epsilon and zeta/delta respectively.  14-3-3 is a 
family of conserved regulatory molecules in eukaryotic cells with seven isotypes 
in human cells (β, γ, ζ, σ, ε, η, τ).  They participate in many biological processes 
including signal transduction and cell cycle control (Wilker and Yaffe, 2004).  
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The presence of 14-3-3 in the cerebrospinal fluid has been associated with 
diseases that cause neuronal damage, such as Alzheimer’s Disease and 
Creutzfeldt-Jakob disease (Zerr et al., 2000, Layfield et al., 1996, Huang et al., 
2003).  Band C was identified to be triosephosphate isomerase, which is also 
reported to be present in AD brain.  This oxidatively modified enzyme is involved 
with energy metabolism and ATP production.  Butterfield and co-workers 
suggested that low levels of ATP cause cognitive decline in AD patients 
(Butterfield et al., 2006).  The final protein identified was glutathion S transferase 
(GST, band D).  Although this enzyme is not currently linked with the disease, it 
is associated with oxidative stress.  Increase in glutathione enzyme may be 
induced during oxidative stress as a cellular defence mechanism (Behl, 1999).    
Baez et. al. (1997)  reported the detoxication capacity and hence neuroprotective 
role of GST.  Therefore, the use of fluorescent labelling enabled the identification 
of disease associated proteins.  Here we show that this technique has the potential 
to be utilised to discover new disease marker, especially when combined with 
other proteomic tools. 
 
6.5 Conclusion 
In this chapter, fluorescein-boronic acid (Fl-BA) has been shown to 
selectively bind glycated proteins, thereby enabling their visualisation post-
electrophoresis prior to protein staining.  This technique is valuable in the analysis 
of complex samples where glycated proteins can be identified without interference 
from other unmodified proteins.  We have utilised this technique to show glycated 
protein variations in diabetic patient serum samples, although the fluorescent band 
intensities cannot be correlated with the level of glycation from the lack of sample 
information.  By analysis of Alzheimer’s Disease mouse brain samples, we have 
identified several proteins that are either currently associated with the disease or 
oxidative stress.  We aim to improve this technique further with the development 
of more selective fluorescent boronic acid molecules.  This method could 
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potentially be used for the detection of disease markers, especially when coupled 
with other proteomics techniques such as 2D gels. 
 
6.6 Final conclusion for Part I 
This section of the thesis demonstrates the development of a new 
electrophoresis method for the detection and visualisation of glycated proteins 
based on their interaction with boronic acids.  We have termed the technique 
methacrylamido phenylboronate acrylamide gel electrophoresis, mP-AGE.  By 
incorporating boronic acid (MPBA) into the gel matrix, glycated proteins can be 
separated from unmodified ones.  This simple method is adaptable for the study of 
a variety of proteins and is complementary to other analysis such as mass 
spectrometry.  Naturally glycosylated proteins do not hamper such analysis 
because they lack anomeric cis diols, structures that are crucial for high boronic 
acid affinity.  In addition, this novel technique can differentiate between different 
glycation states of protein, and distinguish Amadori products formed from the 
reaction with different sugars.   
Improvements to the mP-AGE method enable more dramatic separation 
between glycated proteins and unmodified ones.  The application of priming the 
gel-incorporated MPBA was described, where a carbohydrate template was 
utilised to pre-organise the boronic acid in the gel with the aim to maximise their 
interaction with glycated samples.  Additionally, priming may activate the MPBA 
by altering its complexation pKa and binding affinities.  Nevertheless, prior 
knowledge of the sample is required for the selection of suitable templates.  
Utilisation of boronic acid step gels resulted in enhanced glycated protein 
separations by employing the highest MPBA concentration in the top section of 
the resolving gel.  Furthermore, 2D mP-AGE gels enable clear identification of 
glycated proteins by segregating the affected proteins from unmodified ones 
positioned in the diagonal of the 2D gel.  Although mP-AGE can be used for the 
study of complex protein samples, their analysis is often more complicated.  
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Hence, fluorescein-boronic acid (Fl-BA) is employed for the selective labelling of 
glycated proteins which enables their visualisation prior to protein staining.   
We concluded this section with the application of mP-AGE on the analysis 
of disease model samples.  Several AGE-related proteins were identified from 
Alzheimer’s Disease transgenic mouse sample using Fl-BA labelling, illustrating 
the potential of this technique for the identification of disease markers.  
Nevertheless, further developments are required to give more distinct and intense 
fluorescence signal.   
Additional studies are required for the correlation of in vitro data with that 
of the in vivo process.  Although mP-AGE has been shown to be able to detect 
early glycation products, its correlation with different disease states are not 
established.  In addition, Syrovy (1992) reported that staining with Coomassie 
brilliant blue is decreased in glycated proteins.  However, the presence of boronic 
acid interaction may alter the charge on the neutral sugars and influence their 
staining.  This protein staining effect requires further investigation.  The use of 
fluorescence is therefore beneficial as it provides quantitative sample 
measurements.   
Although glycation was discovered almost a century ago, further studies are 
yet required to fully elucidate its complex mechanisms and implications in 
diseases.  Like other analytical techniques, mP-AGE cannot detect all Amadori 
and AGE products because of the specificity of the boronic acid compounds 
employed.  The utilisation of a mixture of boronic acids with different sample 
specificity in a gel or plate assay to enable differential detection and visualisation 
of various modified proteins is an exciting aspect that will be further investigated 
in our laboratory.  Our protein glycation analysis so far has indicated the potential 
of mP-AGE to become a new proteomics tool for the detection, separation and 
visualisation of glycated proteins.  
  
108 
 
 
 
 
 
 
PART 2 Structural studies of immune evasion protein Sbi and its 
ligand C3d  
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Chapter 7 Introduction 
In this part of the thesis, I will be discussing the interactions between 
complement evasion protein, Sbi, and complement component C3d using X-ray 
crystallography.  Some background regarding the complement system and 
Staphylococcal immune evasion protein Sbi will be introduced, along with the 
methodology of protein expression, purification and crystallisation of the proteins 
Sbi and C3d.  
 
7.1 The complement system 
Complement is part of the innate immune system that acts as the first-line 
host defence against microbial infections (Lesher and Song, 2010).  It is the main 
defence and clearance system in bloodstream that is activated by 
immunoglobulins when antibodies recognise foreign particles (Law and Reid, 
1995).  Complement was first discovered in 1890s when it was found to 
complement the killing of bacteria by heat-stable antibodies present in normal 
serum.  It consists of a network of over 30 proteins that are either soluble and 
present in the blood or as membrane-associated proteins (Walport, 2001, Sarma 
and Ward, 2011).  Under or over activation of complement are associated with 
autoimmune, inflammatory, and neurodegenerative diseases (Qu et al., 2009).  
Complement is a cascade activation system occurring through three pathways, as 
summarised in Figure 7- 1.  
 
Classical pathway  
The classical pathway (CP) initiates during immune complex formation 
when IgG or IgM binds pathogens or other foreign antigens (Ag).  When 
complement component C1q binds the exposed Fc portion of IgG and IgM, serine 
proteases C1s and C1r are activated.  Activated C1 cleaves C4 and C2 to form CP 
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C3 convertase, C4bC2a (Sarma and Ward, 2011).  Activation is also achieved by 
direct interaction of C1 with several polyanions, small polysaccharides, viral 
membranes and C-reactive protein.  This antibody (Ab)-independent activation 
route provides rapid defence against pathogens via innate immune mechanisms 
with serum lectin and protease.  C3 is a major plasma glycoprotein (1.3 mg/ml 
concentration) that plays a central role in both pathways. Classical pathway 
prevents formation of large insoluble complexes.  But if large complexes form, 
the alternative pathway could be activated.  Covalent binding of C3b leads to the 
breaking up of Ab-Ag into small soluble complexes.  Small complexes are then 
cleared by hepatic and splenic macrophages while large insoluble complexes 
require CR1 binding on erythrocytes and are transported to the liver and spleen 
for clearance (Law and Reid, 1995). 
 
Lectin pathway  
The lectin pathway (LP) is triggered when mannose binding lectin (MBL) 
or Ficolin bind carbohydrate moieties on the surfaces of pathogens.  The MBL 
and Ficolin complex with MBL-associated proteins (MASPs) in serum, and 
conformation changes upon pathogen binding auto-activates MASP2, which 
cleaves C4 to C4a and C4b.  C4b then attaches to surface of pathogens inducing 
C2 binding and cleavage by MASP2 to form C2a and C2b.  C4b and C2a form LP 
C3 convertase C4bC2a. 
 
Alternative pathway 
The alternative pathway (AP) is activated by carbohydrate, lipids, and 
proteins on foreign surfaces (Qu et al., 2009).  C3 is constantly hydrolysed to C3b 
which binds target bacteria.  Factor B binds C3b forming C3bB, and Factor D 
cleaves Factor B to form C3 convertase C3bBb, which is stabilised by plasma 
 properdin.  Activation of C3 and factor B in alternative pathway operates 
positive feedback amplification loop 
 
Figure 7- 1 Complement activation pathways.
activation of the three complement 
(LP) pathways.  Adapted from 
 
Downstream reaction
C3 convertases C4bC2a of CP and LP and C3bBb of AP further cleave C3 
to release C3a and C3b.  C3b helps amplification of complement activation and in 
phagocytosis.  C3b complexes with C3 convertases to form C5 convertases 
C3bBbC3b and C4bC2aC3b.  C5 conver
and C5b.  Membrane attack complex (C5b
binding to C5b, and C8 and multiple molecules of C9 binding to C5bC6C7 
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(Law and Reid, 1995). 
  Interaction and complex form
pathways: Classical (CP), Alternative (
Sarma and Ward (2011). 
 
tases subsequently cleave C5 to form C5a 
-9, MAC) is initiated by C6 and C7 
in 
 
ation during 
AP) and Lectin 
 complex.  MAC complex forms 
resulting in cell lysis 
 
C3 
Complement component C3 
and comprises of 2 polypeptide chains of 110 and 75 kDa respectively.  They are 
linked by one disulphide bond and non
Cleavage of C3 by C3 convertase of the classical and alternative pathway gives 
rise to 2 fragments: C3a and C3b.  The inactivated C3b is 
in the presence of factor H to produce a double cleavage in its 
iC3b and C3f (Figure 7
breakdown of iC3b in serum results in 2 products, namely C3c and C3dg 
(Lachmann et al., 1982)
Figure 7- 2 Activation and break down of C3.  The native C3 molecule is activated by the 
classical or alternative pathway C3 convertase.  The 
thioester.  C3b is degraded by factor I in the presence of cofactors into 
C3c and C3dg fragments are obtained from further cleavage by factor I and the cofactors. 
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a pore by inserting itself into cell membra
(Sarma and Ward, 2011). 
is central to all three complement pathways 
-covalent interactions (Janatova, 1986)
then cleaved by factor I 
α-chain to generate 
- 2).  Both surface-bound and in th
. 
α chain of C3b contains the exposed 
nes 
.  
e fluid phase, 
 
iC3b and C3f.  
 
 Removal of C3a induces conformational change in 
molecule which leads to exposure of an internal 
quite inaccessible in 
nucleophiles, including
(Figure 7- 3).  If these molecules are found on cell surface, C3b will become 
covalently bound to cell by ester or amide bond. 
C3, upon its activation, with potential to form covalent
any nucleophile, including hydroxyl and amino groups on any biological surfaces 
of foreign or host origin.  Water, at 
readily hydrolyses the thio
activated C3b (Law and Reid, 1995)
Figure 7- 3 Thioester bond in C3 and C4 
prior to activation consist
glutamine) forming a 15
113 
the C3b portion of 
thioester, which wa
native C3.  The exposed thioester is extremely reactive with 
 water and molecules bearing hydroxyl or amino groups
 Thus internal thio
ly linked complexes with 
a concentration of 55 M in 
ester and effectively limits the spatial range of 
. 
and its activation. (A) Structure of 
s of four amino acids (cysteine, glycine, glutamic acid and 
-membered thiolactone ring.  The polypeptide backbone is shown 
the 
s buried and 
 
ester confers 
the medium, 
the 
 
the thioester 
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in black with the side chains in blue and the thioester in red; adapted from Law and 
Dodds (1997).  (B) The reaction of the exposed activated thioester with water and other 
nucleophiles.  Adapted from Rother et. al. (1998). 
 
7.2 Staphylococcus aureus immunoglobulin binding protein, Sbi  
Many bacterial pathogens are adapted to evade their host immune system 
by affecting complement activation.  This includes the regulation of activation, 
amplification, cell lysis by proteolysis of complement proteins or mimicking the 
action of complement proteins, as well as interacting with complement proteins 
(Sarma and Ward, 2011). 
Staphylococcus aureus (S. aureus) is a gram-positive human pathogen that 
causes infections ranging from minor skin infections to life threatening diseases 
such as meningitis and toxic shock syndrome (TSS).  There are six known 
complement modulators secreted by S. aureus: Staphylococcal complement 
inhibitor (SCIN), fibrinogen-binding protein (EFb-C) and its homologue Ehp, 
Staphylococcal superantigen-like protein 7 (SSL7), chemotaxis inhibitory protein 
of S. aureus (CHIPS) and S. aureus binder of immunoglobulin (Sbi) (Clark et al., 
2011).  Their structures are shown in Figure 7- 4.  
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Figure 7- 4 Structures of S. aureus immune modulator proteins. Sbi-IV (PDB code 
2JVH), Efb-C (PDB 2GOM), Ehp (PDB 2NOJ), SCIN (PDB 2QFF), and protein A 
domain B (PDB 1SS1) are shown in ribbon (top) and schematic (bottom) topology 
representations.  Image taken from Upadhyay et. al. (2008) 
Staphylococcus aureus immunoglobulin binding protein, Sbi, is 436 
residues in length with a unique ability to interact with components of both the 
adaptive and innate immune systems of the host organism (Burman et al., 2008).  
Sbi is an excreted protein that lacks cell wall anchoring LPXTG sequence.  It 
consists of four binding domains, followed by a cell-wall spanning and tyrosine 
rich regions at the C-terminus (Figure 7- 5).  Domains I (amino acids 42-94) and 
II (AA 92-156) are immunoglobulin binding domains, whilst domains III (AA 
150-205) and IV (AA 197-266) bind complement component C3 and cause 
consumption of this most abundant complement component.  An Sbi construct 
containing domains I-IV (Sbi E) and Sbi-III-IV both inhibit all three pathways of 
the complement system whilst Sbi-IV only affects the alternative pathway 
(Burman et al., 2008).  Sbi-IV has previously been studied by NMR and shown to 
have three α-helix bundle fold similar to that of S. aureus complement inhibitors 
Efb-C, Ehp, SCIN and the IgG-binding domains of SpA (Upadhyay et al., 2008).  
The crystal structure of the complex between Sbi-IV and its ligand C3d complex 
was recently determined by Clark et. al. (2011).  The structure of this complex 
revealed two binding modes that involved one molecule of Sbi and one molecule 
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of C3d.  One binding mode involves interactions between Sbi-IV helix 2 with the 
acidic concave surface of C3d.  This binding site is shared by other 
Staphylococcal immune proteins.  When bound in this position, Sbi blocks the 
binding of C3d to complement receptor 2 (CR2) (Isenman et al., 2010). A possible 
second binding mode, observed when investigating the crystal packing 
interactions of the complex, involves interactions between helices 1 and 3 of Sbi-
IV with the thioester region of C3d. 
 
Figure 7- 5 Sbi domain structure showing the signal peptide sequence (S), ligand-binding 
domains (I and II), domains III and IV, cell wall-spanning regions (Wr) and C-terminal 
tyrosine rich region (Y) (Burman et al., 2008). 
 
7.3 X-ray Crystallography 
The atomic resolution structure of a protein can only be revealed by X-ray 
crystallography and nuclear magnetic resonance (NMR) spectroscopy.  Both 
techniques are time consuming and require considerable amounts of purified 
protein.  For X-ray crystallography, protein crystals that diffract X-rays well are 
required for data analysis.  NMR, on the other hand, requires protein samples to 
be labelled with specific isotopes like 13C and 15N for peak assignment to specific 
nuclei in the protein (Price and Nairn, 2009). 
X-rays are electromagnetic radiation of wavelength typically between 0.1 
and 1.0 nm, which is comparable to the intermolecular spacing in crystals.  
Diffraction is obtained when X-rays are incident on the crystal.  Protein crystals 
generally contain large amounts of water (50-60% by weight) and must be kept 
hydrated to retain their internal molecular order.  These molecules are, therefore, 
in a similar hydrated state as those found in living systems (Sherwood and 
Cooper, 2011).  Protein crystals can therefore be described as loose periodic 
network of weak, non-covalent interactions containing large solvent channels for 
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relatively free diffusion of small molecules.  Crystallography provides detailed 
information in well-defined parts of the molecule with no size limitation.   
 
7.4 Aims of studying the interaction between Sbi-III-IV and C3d 
Staphylococcus aureus binder of IgG (Sbi) interacts with both the innate 
and adaptive immune systems of the host.  In this part of the thesis, I will be 
documenting the expression and purification of Sbi and C3d and their co-
crystallisation.  Previous work in our laboratory has shown the presence of two 
binding modes in the Sbi-IV:C3d crystal structure.  The aim of my study is to co-
crystallise Sbi-III-IV with C3d to gain further insight into the interaction of Sbi 
domains with complement component C3d, and their individual roles in C3 
activation.  In addition, the presence of a glycerol molecule was observed at the 
interface between the two molecules in our group’s recently published crystal 
structure (PDB code 2WY8).  This indicates an opportunity for the design of Sbi 
inhibitors.  Therefore, the presence of solvent channel at the molecular interface 
will also be examined.    
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Chapter 8 Materials and method for protein studies 
For protein purifications, ÄKTATMpurifier was used along with affinity and 
ion exchange columns (HisTrap FF and HP, HiTrap DEAE, Q-FF and SP-FF) and 
Pd10 desalting columns from GE Healthcare.  Spin concentrators were obtained 
from Sartorius stedim biotech/ Pierce/ Amicon Ultra. 
Crystallisation equipment included 24-well plates (Molecular Dimensions), 
high vacuum grease (Dow Corning Corp), CrystalCleneTM slips (Molecular 
Dimensions) and CryoMount set (Molecular Dimensions).  Crystallisation screens 
(Morpheus, PACT and Structure Screen 1 and 2) from Molecular Dimensions Ltd 
were used. 
 
8.1 Buffers 
Luria Bertani (LB) medium consisted of 1.0% (w/v) bacto tryptone, 0.5% 
(w/v) yeast extract and 1.0% (w/v) sodium chloride, and was sterilised.  
Antibiotics, 100 µg/ml of ampicillin, were used to supplement the culture 
medium. 
LB agar plates were prepared by adding 1.2% (w/v) agar to the above LB 
medium and autoclaved.  The medium was allowed to cool before supplementing 
with antibiotic.  Plates were allowed to set and stored at 4°C until use. 
 
8.2 Bacterial strains and plasmids for Sbi and C3d re-transformations 
1 µl of plasmid DNA was added to 10 µl BL21(DE3) cells on ice for 30 
min, and heat shocked at 42oC for 45 s before returning on ice for a further 5 min.  
400 µl LB was then added at room temperature and shaken at 200 rpm at 37oC for 
an hour.  100 µl of the mixture was spread onto antibiotic supplemented LB agar 
plate and incubated overnight at 37oC.  A large colony was selected and 
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inoculated into 10 ml LB medium with antibiotic (100 µg/ml ampicillin).  Culture 
grew to an optical density at 600 nm (OD600) of 0.5. 
Sbi-III-IV in pET parallel vector and pQE30 was previously prepared in our 
laboratory (Clark et al., 2011, Burman et al., 2008).  pET15b containing the C3d 
gene was prepared by Professor David Isenman at the University of Toronto, 
Ontario, Canada.  C3d is comprised of amino acids 996 – 1303 of C3.  The C3d 
construct used in this study contains a mutation at AA1010, which substituted a 
cysteine with an alanine for ease of protein purification.   
Glycerol stocks were prepared by the addition of 1 ml culture at OD600 0.5 
in a cryovial with 0.5 ml of 50% glycerol and frozen at -80oC.  Subsequent 
primary cultures were inoculated with glycerol stocks. 
 
8.3 Protein expression and purification 
8.3.1 Protein expression 
10 ml primary culture in LB medium containing antibiotic (100 µg/ml 
ampicillin) was inoculated with the glycerol stock and grown overnight at 37oC 
shaken at 200 rpm.  Primary culture was then inoculated into a 1L secondary 
culture of LB medium supplemented with antibiotics, and incubated at 37oC 
shaken at 200 rpm.  When the cells reach OD600 between 0.6 and 1, they were 
induced with 0.5 mM IPTG and incubated for 3 h at 37oC for Sbi, or overnight at 
16oC for C3d, shaken at 200 rpm.  The cells were harvested by centrifugation at 
8,000 x g for 10 min.  
 
8.3.2 Protein purification by affinity chromatography 
Proteins with histidine tag like Sbi was purified using nickel affinity 
chromatography.  The harvested cell pellet was re-suspended in buffer A (50 mM 
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Tris, 300 mM NaCl, 20 mM imidazole pH 8, with 2% Triton x-100 and protease 
inhibitors from Roche).  Cells were lysed by sonication using Branson Digital 
Sonifier with 10 s blasts at 85% amplitude five times, ensuring the pellet did not 
overheat.  The pellet was then spun at 60,000 x g for 30 min and the supernatant 
was injected into the superloop for loading onto ÄKTATMpurifier.  Purification 
was performed using HisTrap 1 or 5 ml affinity columns.  Protein was eluted with 
an imidazole gradient using buffer B (50 mM Tris, 300 mM NaCl, 500 mM 
imidazole pH 8).  
Proteins with GST tags can be purified as above using GST column with 
buffer A as PBS (containing sodium chloride, potassium chloride and phosphate) 
and buffer B as 50 mM Tris-hydrochloride and 10 mM reduced glutathione pH 8. 
 
8.3.3 Purification by ion exchange chromatography 
As a secondary purification step, or for proteins that do not contain affinity 
tags like C3d, ion exchange chromatography was performed.  Cells should be re-
suspended in a buffer at a pH below the pI of protein for cation exchange, and 
buffer at pH above the pI of the protein for anion exchange.  For C3d, 20 mM Tris 
pH 7.5 was used for anion exchange, and 50 mM MES buffer pH 5.5 was used for 
cation exchange.  Cells were lysed by sonication and spun at 60,000 x g for 30 
min.  Supernatant was loaded onto ÄKTATMpurifier for ion-exchange purification 
using HiTrap Q-FF or DEAE FF column for anion exchange and SP-FF column 
for cation exchange.  Protein was eluted with a NaCl gradient.   
 
Protein concentration 
The protein purification fractions were analysed on SDS-PAGE gels using 
Laemmli buffer system.  The selected protein fractions were buffer exchanged and 
concentrated.  Protein concentrations were estimated either by absorbance at 280 
nm (A280) in 6 M guanidine-HCl or Bradford assay.   
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8.3.4 Complex formation using pull down assay 
Sbi-III-IV:C3d complexes can be formed either by combining the purified 
Sbi-III-IV and C3d proteins in a 1:1 molecular ratio, or performing a pull down 
assay.  In the assay, Sbi was loaded onto a histidine affinity column and used as 
bait for the prey, which is C3d.  The complex was then eluted with an imidazole 
gradient as described in 8.3.2. 
  
8.4 X-ray Crystallisation  
Crystal conditions were set-up with a Phoenix crystallisation robot using 
commercially available screens: Structure Screens 1 and 2 (SSI&II), PACT and 
Morpheus, each containing 96 conditions.   200 nl of 12 mg/ml Sbi-III-IV:C3d 
protein complex in 19 mM Tris and 88 mM NaCl buffer was applied in the sitting 
drop vapour diffusion method and stored in a 16oC incubator.  Successful 
conditions were selected for optimisation using hanging drops incubated at 18oC. 
 
Microseeding 
Small crystals obtained from the crystal optimisation conditions were 
placed in a microcentrifuge tube containing 45 µl buffer consisting of 0.1 M 
HEPES buffer pH 7.5, 20% PEG 2000 and 0.4 mM MPBA, along with Seed 
BeadTM (Hampton Research) and vortexed for 90 seconds.  450 µl of buffer was 
added to the tube and 1:10 serial dilutions were carried out and subsequently used 
to set-up crystal conditions, with hanging drops of a 1:1 ratio of these protein 
solutions to buffer.  
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Crystal data collection and analysis 
The crystal was cryoprotected in a solution containing 0.1 M HEPES buffer 
with 20% (w/v) PEG 2000 and 10% (v/v) glycerol, and flash frozen under a 
nitrogen stream before data collection.  X-ray data sets were collected with an in-
house Rigaku RA-Micro7 HFM tabletop rotating copper anode X-ray generator.  
Data was processed using HKL2000 (Saturn 944) and molecular replacement was 
performed with Balbes (Long et al., 2008) using the C3d sequence (Pdb ID 
1C3D).  Modelling was carried out using Coot (Emsley et al., 2010) and 
refinement with Refmac5 (Murshudov et al., 2011) which is part of CCP4i (Winn 
et al., 2011).  The structure was validated using MolProbity (Davis et al., 2007). 
The crystal screening and optimisation set-up was performed together with 
Yi Yang, who was working on his summer internship project under my 
supervision.  Project students, John Ferdinand and Aikaterini Papadopoulou, 
performed some protein purification and crystal surface interaction analysis 
respectively.  
 Chapter 9 The crystal 
9.1 Results 
9.1.1 Protein expression and purification
Sbi and C3d proteins were expressed using 
FPLC affinity chromatography.  
purified with nickel affinity c
purification provides sufficiently pure samples as shown in 
(Figure 9- 2).   
Figure 9- 1 Typical Sbi elution profile.
protein purification, using 
Figure 9- 2 SDS-PAGE analysis of Sbi
purification fractions.  
(lane 3), insoluble (lane 4) and purified fraction (lane 5); Sbi
induced (lane 7), soluble (lane 8), insoluble (lane 9), purification fractions (lanes 10
Sbi-III-IV purification fractions (lanes 15
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structure of the Sbi-III-IV:C3d complex
 
E.coli system and purified using 
As Sbi proteins contain histidine 
hromatography (Figure 9- 1).  
the SDS
  Nickel affinity HisTrap FF column was used for 
an imidazole gradient (green line) for protein elution
-III, Sbi-IV and Sbi-III-IV
Samples: Sbi-III uninduced (lane 1), induced (lane 2), soluble 
-IV uninduced (lane 6), 
-18)  
 
tag, they were 
This one step 
-PAGE gel 
 
. 
 
 expression and 
-14); 
 C3d, on the other hand
therefore purified by ion exchange chromatography.  
purification and gel profiles of C3d using a
Figure 9- 3 C3d purification using 
C3d in Tris pH 7.5 buffer 
NaCl for protein elution
1), induced (lane 2), insoluble (lane 3), soluble (lane 4), flow through (lane 5), 
purification fractions 
fractions (lanes 15-21).
Samples from lanes 16 and 17 
cation exchange chromatography 
Nonetheless, C3d purification was 
chromatography as the 
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, does not contain His or GST affinity tags, and was 
Figure 9
nion exchange chromatography.
anion exchange chromatography.  
(top) using 5 ml HiTrap Q-FF column with gradient of 0
.  SDS-PAGE gel profiles of samples (bottom)
from Q-FF column A2-A10 (lanes 6-14), DEAE purification 
 
in Figure 9- 3 were further 
(Figure 9- 4).  The samples were 
repeated using cation exchange 
initial purification step (Figure 9- 5). 
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Elution profile of 
 – 1 M 
: uninduced (lane 
purified using 
fairly pure.  
ml
B4 B5
 Figure 9- 4 C3d purification using cation exchange chromatography.  C3d 
anion exchange (Figure 9
buffer and run on SP
repurification (lane 1), flow through (lane 2), purificatio
Figure 9- 5 C3d purification using cation exchange chromatography.  Elution profile of 
C3d (left) in MES pH 5.5 buffer using 5 ml HiTrap SP
0.5 M NaCl for protein 
(lane 1), purification fractions (lanes 
 
9.1.2 Purification of the 
As mentioned above, the 
combining the two purified 
example, complex formation of 
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- 3 lanes 16 and 17) were buffer exchanged into 
-FF column, eluting with salt gradient.  Samples: before 
n fractions (lanes 3
 
-FF column with gradient of 0
elution.  SDS-PAGE gel profiles of samples (right
2-6). 
Sbi-III-IV:C3d complex 
Sbi-III-IV:C3d complex can be 
proteins or performing a pull-down assay.
Sbi-IV:C3d was performed by a 
 his5HP017:10_Flow  his5HP017:10_Fractions
 60  80 100 120 ml
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sample after 
MES pH 5.5 
-7). 
 
 – 
): flow through 
formed by 
  As an 
pull down assay 
 (Figure 9- 6) whist 
purified proteins in a 1:1 molecular ratio (
Figure 9- 6 Elution profile and 
with a HisTrap column and 
imidazole gradient.  Sbi
induced (lane 4), insoluble (lan
(lane 7), C3d loading flow through (lane 
The ratio of Sbi and C3d appears to vary in the different elution fractions.  
Therefore, it was decided to 
However, the eluted
protein ratio variation
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Sbi-III-IV:C3d was performed by direct addition of both 
Figure 9- 8).  
purification of Sbi-IV:C3d complex. Sbi
C3d was loaded before the complex was elut
-IV induced (lane 1), insoluble (lane 2), soluble (lane 3
e 5), soluble (lane 6), Sbi-IV column loading flow through 
8), purification fractions B3 – B6
collect all fractions and re-purify this complex.  
 fractions of the re-purified protein still show
 (Figure 9- 7).   
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-IV was purified 
ed using an 
), C3d 
 (lanes 9-12). 
ed the same 
ml
B9 B10 Waste
 Figure 9- 7 Re-purification 
before repurification (lane 1), f
It therefore seems more consistent to purify the proteins separately and 
combine the proteins to get the required molar ratio of 
Figure 9- 8 Sbi-III-IV soluble (lane 1), insoluble (lane 2), purification fractions (lanes 3 
and 4), uninduced (lane 5), induced (lane 6) and Sbi
 
9.1.3 Co-crystallisation of the 
Protein complex 
crystallisation screens 
were observed in 30% PEG 1500 (D11) from SSI&
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of Sbi-IV:C3d fractions from the pull down assay. 
low through (lane 2), fractions C15, D2 –
complex (Figure 9
-III-IV:C3d complex (lane C).
Sbi-III-IV:C3d complex  
(at concentration of 12 mg/ml) was used to set up 
with 1:1 ratio of protein to buffer in sitting drops.  C
II, and also condition C11
Complex 
D7 (lanes 3-8). 
- 8). 
 
 
rystals 
.  
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Numerous needle-like, amorphous and crystalline crystals were found in the 
PACT screen conditions containing various buffers between pH 6 and 8 with 25% 
PEG 2500 (conditions A3, A4, B4, B5, C1, C5, D4, D5, F10 and G7).  Crystals 
were also seen in the Morpheus screen conditions with PEG 2000 and buffer 
conditions between pH 6.5 and 7.5 (wells D1, D4, D5, E1 and F1).  Conditions of 
the screens are detailed in appendix A5.  Crystals were optimised in 0.1 M 
HEPES buffer pH 7.5 with 15 to 30% PEG 2000.  Additives of 0.05 M glucose 
and/or fructose or 0.4 mM methacrylamido phenylboronic acid (MPBA) were 
used.  The best condition was 15% PEG 2000 with 0.05 M glucose and 0.05 M 
fructose, and 20% PEG 2000 with 0.4 mM MPBA with a 1:1 ratio of protein and 
buffer in droplets.  Screens were performed around these conditions using 15, 20 
and 25% PEG 1000 and 2000 containing glucose, fructose and MPBA additives.  
Subsequent crystals obtained in wells containing 20% PEG 2000 with 0.2 mM 
MPBA and 0.4 mM MPBA with protein to buffer ratio of 1:2 were used in 
microseeding.  The resulting crystal from the seeding plate (Figure 9- 9) was 
analysed by X-ray diffraction.  The statistics from data collection and refinement 
are summarised in Tables 9- 1 and 2 and Ramachandran plot shown in Figure 9- 
10. 
129 
 
 
 
Figure 9- 9 Selection of crystals obtained from microseeding using 0.1 M HEPES buffer 
pH 7.5 with 20% PEG 2000 and 0.4 mM methacrylamido phenylboronic acid (MPBA). 
 
Table 9- 1 Crystal data collection statistics. 
Unit cell dimensions a = 48.8 Å, b = 86.2 Å, c = 49.3 Å; 
α = 90o, β = 117o, γ = 90o 
Space group P21 
Molecules/ asymmetric unit 2 
Resolution (Å) 1.85 
Measured reflections 248146 
Unique reflections 24791 
Resolution range (Å) 50 – 1.85 (1.88 – 1.85) 
Rmerge 0.036 (0.082) 
I/σI 38.63 (17.45) 
Multiplicity 2.4 (1.6) 
Completeness (%) 79.8 (59.4) 
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Table 9- 2 Crystal refinement statistics. 
Resolution (Å) 1.85 
R (%) 16.2 
Rfree (%) 22.6 
Number of atoms 3418 
Number of residues 359 
Number of water molecules 376 
Rmsd bond lengths (Å) 0.013 
Rmsd angles (o) 1.328 
Wilson B-value overall 14.597 
Wilson B-value average 13.874 
Estimated coordinate error 
base on Rfree (Å) 
0.174 
 
Table 9- 3 Quality validation statistics of the structure using MolProbity. Clashscore 
corresponds to the number of serious steric overlaps of > 0.4 Å per 1000 atoms.  This 
clash score places the structure at the 89th percentile, where 100th percentile is the best 
structures of comparable resolution.  The MolProbity score is of 97th percentile. 
Clash score 7.31 
Poor rotamers (%) 1 
Ramachandran outliers (%) 0 
Ramachandran favoured (%) 98.6 
Cβ deviations (> 0.25 Å) 0 
MolProbity score 1.40 
Residues with bad bonds (%) 0 
Residues with bad angles (%) 0 
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Figure 9- 10 Ramachandran plot generated with Procheck as part of CCP4 software.  
Based on the analysis of 118 structures of resolution of at least 2.0 Å and R-factor no 
greater than 20%, a good quality model would be expected to have over 90% of residues 
in the most favoured regions. 
 
 Investigating stability of Sbi
After initial analysis of the crystal structure following molecular 
replacement, it became clear there was no 
determined crystal structur
the domain or protein cleavage.  
as that analysed by X
determine the protein composition (
found together with cleaved Sbi protein
Figure 9- 11 SDS-PAGE analysis of a seeded crystal. 
molecular weight of C3d and Sbi
cleavage products of Sbi (
 Several other crystals were 
confirm cleavage of Sb
under crystallisation condition was investigated (
can be seen that Sbi
completely degraded into Sbi
C3d.  In order to crystallise the Sbi
the same crystal condition at 4
one month.  Proteins may crystallise under completely different conditions under 
different temperatures, therefore, large scale crystallisation screening should be 
repeated. 
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-III-IV under crystallisation condition
Sbi domain III present in the 
e.  The two possible explanations include f
Hence, crystals obtained from a similar 
-ray crystallography were analysed on an SDS
Figure 9- 11).  The C3d protein band was 
.   
 
 Black arrows indicate 
-III-IV.  However, only C3d is present along with 
indicated by blue arrows). 
subsequently analysed by electrophoresis to 
i-III-IV.  Consequently, stability of this protein complex 
Figure 9- 12).  From the gel, it 
-III-IV started to degrade after one day at 18
-III and Sbi-IV after 4 days, even in the presence of 
-III-IV:C3d complex, we attempted to set
oC.  Unfortunately no crystals were observed after 
s 
lexibility of 
condition 
-PAGE gel to 
the 
oC and was 
-up 
 Figure 9- 12 Stability of Sbi
PAGE profile of Sbi-III
(lanes 0 to 4 respectively). 
 
9.1.4 Structure of 
A 1.85 Å resolution 
complex crystal.  However, Sbi domai
Sbi-IV:C3d structure was solved using molecular replacement and refined using 
refmac5.  In contrast with the previous
complex which crystallised in space group 
complex shows P21 
The interactions between Sbi
shown in ribbon representation in
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-III-IV:C3d complex under crystallisation condition.  SDS
-IV and Sbi-III-IV:C3d complex incubated at 18
 
Sbi-IV:C3d co-crystal 
structure was obtained from the Sbi
n III was cleaved during crystallisation and 
ly published structure of the Sbi
P212121, this proteolytically cleaved 
symmetry, and will be referred to as the P2
-V and C3d observed in this P21 
 Figure 9- 13.  
 
-
oC for 0 to 4 days 
-III-IV:C3d 
-IV:C3d 
1 crystal form.  
crystal form are 
 Figure 9- 13 Ribbon representation of 
Sbi-IV in pink and symmetry related Sbi in blue in the different orientations: (A) side and 
(B) top of Sbi:C3d complex, and (C) front and (D) side views of C3d showing the 2 
different binding modes of Sbi.  Im
In this P21 structure
helices connected by loops
domain by Upadhyay 
helices in an α-α barrel conformation
described by Nagar et. al.
between the inner and outer barrel 
whilst surrounded by 6 helices that are anti
 
A 
C 
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Sbi-IV:C3d complex.  C3d is shown in green and 
ages generated with PyMOL. 
, Sbi-IV adopts a three-helix bundle conformation, 
, as previously observed in the unliganded Sbi
et. al. (2008).  The C3d component is comprised of 12 
, identical to the unliganded C3d structure 
 (1998).   The C3d’s twelve consecutive 
in a manner such that 6 helices 
-parallel to the core. 
B 
D 
 
 
with 
-IV 
α-
helices alternate 
form the core 
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9.1.5 Comparison of the interactions observed in the P212121 and P21 
crystal forms 
The protein interfaces, surfaces and assemblies service (PISA, 
http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html) was used for comparing the 
protein interactions (Krissinel and Henrick, 2007).  The observed protein 
interactions between Sbi-IV and C3d in the P21 crystal form are very similar to 
those previously published in the P212121 crystal form (Clark et al., 2011).  Table 
9- 4 compares the interactions between Sbi-IV and C3d in the two crystal forms.  
These interaction surfaces are very similar, both in terms of the interacting 
residues and buried surface area.  The full list of interacting residues can be found 
in appendix A6.   Molecular surface images were generated using GRASP to 
show this resemblance (Figure 9- 14). 
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Table 9- 4 Crystal surface characteristics of Sbi-IV:C3d interactions.  The first table 
refers to the statistics for the previously published P212121 crystal form (PDB code 
2WY8) and the bottom table is the comparison data for the P21 crystal form.  ASA is the 
solvent accessible area and BSA is the buried surface area. 
Interface Number of 
atoms (%) 
Number of 
residues (%) 
ASA (Å2) 
(%) 
Total BSA  
(Å2) 
 Sbi-IV C3d Sbi-IV C3d Sbi-IV C3d  
A 72 
(13.6) 
90 
(3.9) 
17 
(25.8) 
26 
(8.9) 
803.8 
(16.4) 
731.2 
(6.0) 
1535 
B 65 
(12.3) 
68 
(3.0) 
17 
(25.8) 
17 
(5.8) 
610.4 
(12.4) 
637.7 
(5.2) 
1248.1 
C 17 (3.2) 23 
(1.0) 
5  (7.6) 6  
(2.1) 
187.0 
(3.8) 
158.5 
(1.3) 
345.5 
D 3 (0.6) 1 
(0.0) 
1  (1.5) 1  
(0.3) 
8.4  
(0.2) 
8.4 
(0.1) 
16.8 
 
Interface Number of 
atoms (%) 
Number of 
residues (%) 
ASA (Å2) 
(%) 
TOTAL 
BSA  (Å2) 
 Sbi-IV C3d Sbi-IV C3d Sbi-IV C3d  
A 77 
(14.3) 
89 
(3.8) 
19 
(28.4) 
26 
(8.8) 
757.7 
(14.8) 
710.2 
(5.8) 
1467.9 
B 68 
(12.7) 
67 
(2.9) 
18 
(26.9) 
19 
(6.5) 
640.8 
(12.5) 
645.4 
(5.3) 
1286.2 
C 18 (3.4) 26 
(1.1) 
7 (10.4) 9  
(3.1) 
193.7 
(3.8) 
188.5 
(1.6) 
382.2 
D 4 (0.7) 9 
(0.4) 
2  (3.0) 4  
(1.4) 
40.4 
(0.8) 
37.9 
(0.3) 
78.3 
E 2 (0.4) 2 
(0.1) 
1  (1.5) 1  
(0.3) 
9.6  
(0.2) 
9.9  
(0.1) 
19.5 
 
 Figure 9- 14 Molecular surface 
C3d in the (A) P212121
side (left) and convex side (right) of C3d
The interaction
the two crystal forms, 
are illustrated in Figure 9
different crystal packing obtained.  
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representations of the interaction surfaces
 (PBD code 2WY8), and (B) the P21 crystal forms
.  
s between C3d molecules, on the other hand, are
and are summarised in Table 9- 5.  The interacting residues 
- 15 and are listed in appendix A6.  This may explain the 
 
 
 of Sbi-IV on 
 on the concave 
 different in 
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Table 9- 5 Crystal surface characteristics of C3d:C3d interactions.  The top table refers to 
the statistics for the P212121 crystal form (PDB code 2WY8) and the bottom table is the 
corresponding data for the P21 crystal form.  ASA is the solvent accessible area and BSA 
is the buried surface area. 
Interface Number of 
atoms (%) 
Number of 
residues (%) 
ASA (Å2) 
(%) 
Total BSA  
(Å2) 
 C3d C3d C3d C3d C3d C3d  
i 31 
(1.3) 
40 
(1.7) 
11 
(3.8) 
11 
(3.8) 
367.4 
(3.0) 
337.5 
(2.8) 
704.9 
ii 42 
(1.8) 
32 
(1.4) 
14 
(4.8) 
10 
(3.4) 
297.4 
(2.4) 
346.8 
(2.8) 
644.2 
iii 1   
(0.0) 
3   
(0.1) 
1   
(0.3) 
1   
(0.3) 
3.8 
(0.0) 
4.0   
(0.0) 
7.8 
 
Interface Number of 
atoms (%) 
Number of 
residues (%) 
ASA (Å2) 
(%) 
Total BSA  
(Å2) 
 C3d C3d C3d C3d C3d C3d  
i 34 
(1.5) 
34 
(1.5) 
10 
(3.4) 
12 
(4.1) 
337.2 
(2.8) 
341.6 
(2.8) 
678.8 
ii 28 
(1.2) 
22 
(0.9) 
11 
(3.7) 
6 
(2.0) 
224.9 
(1.8) 
229.4 
(1.9) 
454.3 
iii 11 
(0.5) 
13 
(0.6) 
5 
(1.7) 
4 
(1.4) 
71.7 
(0.6) 
71.9 
(0.6) 
143.6 
 
 Figure 9- 15 Molecular surface 
onto the surface on C3d 
P21 crystal form. (C) shows the crystal packing intera
C3d structure (PBD code
side of C3d whilst the convex side 
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representations of the crystal packing interaction
in (A) the P212121 crystal form (PBD code 2WY
ctions observed in the unliganded 
 1C3D), for comparison.  Image on the left shows the
of the molecule is shown on the right
 
s mapped 
8) and (B) the 
 concave 
.  
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9.2 Discussion 
9.2.1 Protein expression and purification 
Sbi-III, Sbi-IV and Sbi-III-IV proteins all contain an N-terminal histidine 
tag and were purified using a one-step nickel affinity chromatography which gave 
sufficiently pure proteins.  C3d, on the other hand, was purified using ion 
exchange chromatography.  Cationic exchange chromatography gave purer 
protein samples compared to the anionic method used.  Using the pull-down assay 
enabled the Sbi:C3d complex to be obtained in a single purification step.  There 
were, however, difficulties in obtaining the correct molecular ratios of the two 
proteins, even when low salt concentration was used in the loading and washing 
steps.  One way of correcting the protein complex stoichiometry is to combine the 
different purified proteins fractions.  This is because, theoretically, the proteins 
were initially bound in a 1:1 ratio on the column before the complex was eluted, 
providing excess C3d bait protein was used.  An alternative is to estimate the 
concentration of Sbi and C3d in the collected sample.  This can be done by SDS-
PAGE, or using the A280 and Bradford assay.  The intensity of the protein bands 
after Coomassie staining should be proportional to the protein concentration. 
However, this method of estimation may overestimate the concentrations of high 
molecular weight proteins as they tend to stain better with Coomassie blue.  
Alternatively, the C3d concentration can be determined with A280 since Sbi-IV 
does not have extinction coefficient at 280 nm, and the concentration of the 
complex can be determined with the Bradford assay.  The concentration of the 
components can then be adjusted to a 1:1 molecular ratio accordingly.  However, 
it seems more straightforward to purify the two proteins separately and then 
combine them to give the protein complex.   
 
9.2.2 Protein co-crystallisation 
Sbi-III-IV:C3d complex was purified and concentrated for crystallisation 
trials.  Commercial screens were used in the initial crystal screening and the best 
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conditions were selected for crystal optimisation and subsequently microseeding.  
The crystals were then analysed by X-ray crystallography, indexed with 
HKL2000 and the structure solved using molecular replacement and revealed the 
absence of Sbi domain III.   
 
Protein crystallisation condition with methacrylamido phenylboronic acid 
Methacrylamido phenylboronic acid (MPBA) was initially used as an 
additive in the crystallisation condition to aid the crystallisation of the 
gluconoylated protein anticipating that the boronic acid interaction may stabilise 
the complex (as discussed in part 1 of the thesis in section 3.3.7).  Surprisingly, 
the crystal condition in the presence of MPBA gave the biggest crystals amongst 
the optimisation conditions tested, whilst the same condition without MPBA did 
not result in any crystals.  Other additives tested include glucose and fructose, 
which also resulted in crystals.  Hence, further crystal screen optimisations 
involved the use of all these additives.  The crystal analysed by X-ray 
crystallography used the buffer containing 0.1 M HEPES pH 7.5, 20% PEG 2000 
and 0.4 mM MPBA.  Nevertheless, MPBA was not observed in the solved 
structure, because the Sbi domain III was proteolytically cleaved.  The reason why 
MPBA aided the crystallisation of the complex is unknown.  It may be a result of 
boronic acid interaction with the gluconoylated Sbi, thereby eliminating protein 
hetereogeneity in solution and facilitating C3d complexation with the unmodified 
proteins.   
 
9.2.3 Analysis of the Sbi-IV:C3d cocrystal structure 
We have determined that Sbi-III-IV:C3d was proteolytically cleaved during 
crystallisation, therefore, domain III was not observed in the crystal structure.   
The crystal structure of the Sbi-IV:C3d gave good refinement statistics with R and 
Rfree values of 16.2% and 22.6%, respectively.  The 1.85 Å resolution structure 
 shows the presence of one molecule of Sbi
asymmetric unit.  This molecular ratio between Sbi
previously reported 
2W8Y) has a P21212
symmetry.  Nevertheless, the
16), one where Sbi interacts with the concave face of C3d, and the other on the 
convex side.   
Figure 9- 16 Pictorial representation of the two different binding mo
established from the crystal structure
The interaction on the concave side 
Sbi-IV, whilst the second interaction on the convex side of C3d involves the 
and α3 helices of a symmertry related Sb
interaction with Sbi-
exposed upon activation.  This binding mode is not seen in other Staphylococcal 
complement inhibitors such as Efb
The similarities and differences between the interactions of Sbi
C3d, and that of C3d molecules in both structures
interface was found between Sbi
compared to the P212
structures (A in both crystal forms) has buried surface area (BSA) of 1535 and 
1468 Å2 respectively.  This interaction takes 
(shown in purple in P2
interface, the number of residues is comparable, with 17 in the P2
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-IV and one molecule of C3d in each 
-IV and C3d has been 
(Clark et al., 2011).  The published structure (PBD code 
1 space group while this newly solved structure has a P2
 same two binding modes were observed (
des of Sbi
. 
of C3d mainly involves the 
i-IV molecule.  The C3d convex face 
IV takes place at the thioester region of C3, which is only 
-C and Ehp.   
 were analysed.  One extra 
-IV and C3d in the P21 crystal form (
121 form.  The largest interface in the P212
place on the concave side of C3d 
12121 form and green in the P21 form, Figure 9 
1 
Figure 9- 
 
-IV on C3d 
α2 helix of 
α1 
-IV and 
Table 9- 4) 
121 and the P21 
-15).  At this 
12121 structure 
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and 19 in the other crystal form.  The second interface (B) involves BSA of 
1248.1 Å2 in the P212121 form and 1286.2 Å2 in the P21 form, and is found on the 
convex side of C3d (shown in light blue in the P212121 form and blue in the P21 
form).  Three hydrogen bonds were present in both crystal structures which 
involve almost the same residues.  However, the P212121 form has one less salt 
bridge interaction than the P21 form.  Overall, the interacting residues and 
interfaces between Sbi-IV and C3d are very similar in both crystal forms.   
In contrast, the C3d crystal contact interactions are very different between 
the P212121 and the P21 crystal forms.  Of the three interfaces present, only 
interface (i) has similar interacting residues, solvent accessibility and buried 
surface areas.  However, the residues involved in the hydrogen bond interactions 
found at this interface are significantly different, with eight found in the P212121 
crystal form compared to only three in the P21 form.  This interface contains a salt 
bridge in the P212121 form but none in the P21 form.  The other interfaces are also 
very different in terms of interacting residues, buried surface areas and their 
interactions.   
From these results, we can conclude that the Sbi-IV interactions in both the 
concave and convex side of C3d are physiologically relevant.  They are both 
present in two very different crystal forms and are therefore unlikely to be a 
crystallisation artefact.  Despite the presence of a glycerol molecule in the P21 
crystal structure, it is not located at the molecular interface as found in the P212121 
structure.  Nevertheless, the presence of PEG and glycerol molecules in the P21 
form suggests the presence of solvent channels within the structure which may be 
used for the design of Sbi drug inhibitors.  Soaking studies have to be performed 
to identify the feasibility of this scheme. 
The newly solved P21 crystal form gave insights into protein-protein 
interactions of Sbi-IV and C3d within this crystal form.  Nevertheless, further 
studies are required to elucidate the mechanism of Sbi-III-IV in the inhibition of 
complement pathways.  The interaction of Sbi-IV with C3d inhibits C3d 
interaction with complement receptor 2 (CR2).  This binding may also cause 
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conformation changes in the C3d molecule which allows Sbi-IV to interact with 
the convex side of the molecule.  Whilst Sbi-IV only inhibits the alternative 
pathway, in the presence of domain III (Sbi-III-IV) all three complement 
pathways are inhibited from the futile consumption of C3 (Burman et al., 2008).  
This indicates that the Sbi domains play a different role in the interaction with 
complement components, and their mechanism is yet to be elucidated.  
Crystallisation of Sbi-III-IV in complex with C3d, together with other protein 
interaction analysis such as NMR, would shed light onto the interactions and 
induced conformational changes that take place during complement inhibition.   
 
9.3 Conclusion and future work 
Staphylococcal aureus is an opportunistic pathogen that can regulate the 
innate and adaptive immune systems of the host by secreting immune modulators. 
S. aureus binder of immunoglobulin, Sbi, is the most recently characterised of the 
six known complement modulators.  This section of the thesis reports the co-
crystallisation of Sbi domain IV with complement component C3d.  The 1.85 Å 
resolution crystal structure has a P21 symmetry, which is different to the reported 
P212121 space group of the previously published structure (PDB code 2WY8).  
Analysis of the interacting residues revealed similar Sbi-IV interactions with C3d 
between these structures, but very different C3d – C3d crystal packing 
interactions.   
Evaluation of the reported Sbi:C3d interactions and their significance are 
on-going work in our laboratory.  The crystallisation of Sbi-III-IV:C3d will 
elucidate mechanistic roles of the Sbi domains on complement inhibition.  
Mutation analysis, and other structural techniques such as NMR would 
complement these crystal structural data in the elucidation of protein interactions 
and conformational changes.     
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Chapter 11 Appendices 
A1 Boronic acid characterisation by NMR 
1H NMR for the MPBA intermediate, N-(3-(5,5-dimethyl-1,3,2-dioxaborinan-
2yl)phenyl)methacrylamide 
 
13C NMR for the MPBA intermediate, N-(3-(5,5-dimethyl-1,3,2-dioxaborinan-
2yl)phenyl)methacrylamide 
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11B NMR for the MPBA intermediate, N-(3-(5,5-dimethyl-1,3,2-dioxaborinan-
2yl)phenyl)methacrylamide 
 
1H NMR for MPBA 
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13C NMR for MPBA 
 
11B NMR for MPBA 
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A2 Boronic acid characterisation by Mass Spectrometry (MS) 
Mass spectrum of the MPBA intermediate, N-(3-(5,5-dimethyl-1,3,2-
dioxaborinan-2yl)phenyl)methacrylamido (top, MW 205) and MPBA (bottom, 
MW 273) using positive ionisation mode. 
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A3 Mascot search results of the transgenic mouse brain protein bands 
excised from polyacrylamide gel, which were analysed by MS.  Proteins were 
identified by peptide mass fingerprinting using the SwissProt database.  Data for 
band A in Figure 6- 6. 
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Mascot search result of band B in Figure 6- 6. 
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Mascot search result of band C in Figure 6- 6. 
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Mascot search result of band D in Figure 6- 6. 
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Mascot search result of band E in Figure 6- 6. 
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A4 Protein sequences 
Sbi-III-IV in pET parallel vector used in glycation studies 
MSYYHHHHHHDYDIPTTENLYFQGAMERQNIENADKAIKDFQDNKAPHD
KSAAYEANSKLPKDLRDKNNRFVEKVSIEKAIVRHDERVKSANDAISKLN
EKDSIENRRLAQREVNKAPMDVKEHLQKQLDALVAQKDAEKKVA 
 
Sbi-III-IV in pQE30 used in crystallography 
MRGSHHHHHHMERQNIENADKAIKDFQDNKAPHDKSAAYEANSKLPKD
LRDKNNRFVEKVSIEKAIVRHDERVKSANDAISKLNEKDSIENRRLAQREV
NKAPMDVKEHLQKQLDALVAQKDAEKKVA 
 
Sbi-IV in pQE30 
MRGSHHHHHHMVSIEKAIVRHDERVKSANDAISKLNEKDSIENRRLAQRE 
VNKAPMDVKEHLQKQLDALVAQKDAEKKVA 
 
C3d in pET15b 
MLDAERLKHLIVTPSGAGEQNMIGMTPTVIAVHYLDETEQWEKFGLEKR
QGALELIKKGYTQQLAFRQPSSAFAAFVKRAPSTWLTAYVVKVFSLAVNL
IAIDSQVLCGAVKWLILEKQKPDGVFQEDAPVIHQEMIGGLRNNNEKDMA
LTAFVLISLQEAKDICEEQVNSLPGSITKAGDFLEANYMNLQRSYTVAIAG
YALAQMGRLKGPLLNKFLTTAKDKNRWEDPGKQLYNVEATSYALLALL
QLKDFDFVPPVVRWLNEQRYYGGGYGSTQATFMVFQALAQYQKDAPDH
QELNLDVSLQLPSR  
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A4 Crystal screens 
Structural screen 1 and 2 from Molecular Dimensions 
 
178 
 
 
  
179 
 
PACT premierTM from Molecular Dimensions  
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Morpheus from Molecular Dimensions 
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 A5 Interacting residues in the 
 
Table showing the interacting residues 
interfaces in the P212
forms. 
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P212121 (PDB code 2WY8) and P21 
at the Sbi-IV (Q, red) and C3d 
121 (PDB code 2WY8, top) and the P21 (bottom) 
 
crystal forms 
(A, green) 
crystal 
 
  
Table showing the interacting residues between C3d molecules in the 
(PDB code 2WY8, top
184 
) and the P21 (bottom) crystal forms.  
P212121 
 
 Table showing the interacting residues 
Sbi-IV (Q, red) and C3d (A, green) in the crystal 
and the P21 (bottom) 
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involved in the hydrogen bonds 
P212121 (PDB code 2WY8, 
crystal forms.  
 
between 
top) 
 
 Table showing the interacting residues 
C3d molecules in the 
forms. 
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involved in hydrogen bonding 
P212121 (PDB code 2WY8, top) and the P21 
 
between 
(bottom) crystal 
 
 Table showing the interacting residues involved in 
(Q, red) and C3d (A, green) in the 
(bottom) crystal forms
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salt bridges between Sbi
P212121 (PDB code 2WY8, top)
. 
-IV 
 and the P21 
 
 Table showing the interacting residues involved in 
molecules in the P212
forms. 
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salt bridges between C3d 
121 (PDB code 2WY8, top) and the P21 (bottom) crystal 
 
